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Chapter 1 
 
                                                        Introduction 
 
Tuberculosis  
Tuberculosis (TB) is an infectious disease caused by the pathogen Mycobacterium 
tuberculosis. Scientists have been able to discover the DNA of M. tuberculosis in 
Egyptian mummies as early as 2000 B.C. (1). It is identified by various names in the 
historical texts, few of those terms being “consumption”, “wasting away”, and “the white 
plague”, etc. (2). As tubercle bacilli can be spread through air, TB is termed a contagious 
disease. The developing nations of the world are at utmost risk of being easily infected 
due to their high population size and poor living conditions. Although a lot of 
improvements have taken place in the therapeutic regimen for TB by improving diet, 
housing, education, and sanitation conditions there seems to be bigger challenges with 
increasing cost of drugs and the length of therapy (3).  
Since the early 20th century Bacillus Calmette-Guérin (BCG) vaccine has been 
used to prevent TB infection. BCG vaccine consists of live attenuated tubercle bacilli that 
are aimed to act as a prophylactic measure to prevent TB. The duration of protection 
rendered by the vaccine seems to be around 15 years. However, BCG is ineffective to 
prevent adult pulmonary tuberculosis as well as reactivation of latent TB in individuals 
who carry the bacteria without displaying any symptoms of the disease (4). It is estimated 
that 2.2 billion people are infected worldwide annually and approximately 1.3 millions 
deaths occur in HIV-negative people and approximately half a million deaths in HIV-
positive patients (5,6). Another pressing issue in the battle against TB is the increase in 
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the number of strains that are resistant to first line and second line TB drugs. These multi-
drug resistant (MDR) and extensively drug resistant (XDR) strains of M. tuberculosis 
curtail the potency of chemotherapy associated with TB and thus defining a global 
emergency to overcome these roadblocks in TB treatment (7).  
The infection begins through the inhalation of aerosols containing M. tuberculosis 
released from the lungs of an infected individual by coughing or intaking contaminated 
food. The disease typically affects the lungs but can also spread to other parts of the 
body. Upon inhalation of mycobacterium-laden aerosol, the microbe is engulfed by 
alveolar macrophage. During this stage the majority of the bacteria is destroyed, but some 
that resist the harsh intracellular condition are able to survive, multiply, and infect 
neighboring macrophages (8). In general, the disease has two patterns. In the first kind, 
known as the primary TB, the mycobacteria are engulfed by the host alveolar 
macrophage that is then carried to hilar lymph node in order to control the infection. 
During the primary infection, the initial focus of infection is identified as a tiny 
granuloma (tubercle) in the lung tissue also called Ghon’s complex. The primary TB is 
seen mostly in children and majority of these cases resolve as the infant begins to develop 
immunity (80% of cases) whereas sometimes the bacteria enter into a state of dormancy 
and remains undetectable by the host immune system. A secondary TB is a pattern of the 
disease that arises as a result of reactivation of previous infection, exogenous reinfection, 
or gradual progression of primary TB into chronic form mainly due to deteriorating 
health status. The reactivation of latent TB infection can happen when the immune 
system is weakened due to another infection, drug abuse, or immune compromise that 
enable the dormant bacilli to break out of latency and enter an actively dividing state. In 
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the secondary TB the granulomatous inflammation is severe and widespread along with 
extensive cavitation and lung tissue damage. The symptoms of active disease include 
persistent fevers, night sweats, severe cough, sputum with blood, fatigue, and weight loss 
(9).  
M. tuberculosis can remain latent inside the human host for decades and the 
immense reservoir of infected individuals created by this microorganism has a potential 
to develop active tuberculosis (TB) sometime in their life time (10). Approximately, 50% 
of latent infection can lead to reactivation of TB (Fig.1.1). According to the world health 
organization, it is estimated that about one-third of the world’s population is infected with  
latent TB. Latency of M. tuberculosis is described as a state of the bacillus where it is 
metabolically minimally active or in a non-replicating stage for undefined periods of 
time. A person with latent TB is not yet ill with the disease and despite being a reservoir 
for the pathogen cannot transmit the disease to other people. Therefore, latent TB 
infection is marked by the presence of the tubercle bacilli in the body without displaying 
any symptoms, or radiographic, or bacteriologic evidence of TB disease (11). Fig. 1.1 
describes different stages of TB infection in humans. 
Diagnosis of latent TB and active TB can be difficult although the general 
guidelines observed for TB diagnosis entails Mantoux tuberculin skin test (TST) and 
interferon-gamma release assays (IGRAs). Although TST cannot distinguish between TB 
infection and TB disease, a more confirmatory screening is accomplished by chest X-ray 
studies that can provide details as to the location of an infiltrate, cavities and/or fluid in 
the lungs. Finally, a confirmatory laboratory test known as acid-fast bacilli smear (AFB 
smear) is performed in order to microscopically analyze the presence of mycobacteria in 
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sputum obtained from patients with active TB. Apart from these early diagnostic 
measures, an additional test that is made mandatory recently is the drug susceptibility test 
carried out with initial isolates in order to determine what should be the preferred anti-
tuberculosis regimen.  
 
 
 
Fig. 1.1: Stages of M. tuberculosis infection. Inhalation of aerosol can either lead to active or in-
active (latent) TB. Latent TB carriers have the potential to develop infectious, active TB anytime during 
their lifetime. Progression from latent to active TB can be triggered by immune suppression, especially 
during human immunodeficiency virus (HIV) infection. Treatment of drug-susceptible (DS)-TB (denoted 
by asterisk), is successful 95% of the cases, whereas 5% relapse. If untreated (denoted by two asterisks), 
chance of mortality is approximately 50%. Image adopted from (11). 
 
Even though the bacterial burden in the latent TB infection is small compared to 
active TB disease, the treatment period for the latent TB is no different from the active 
TB therapy: both require around 6-9 months of treatment period. For latent TB infection, 
two drugs are administered; isoniazid and rifampicin. The treatment plan for active TB 
comes in two phases; an initial phase of 2 months, followed by a continuation phase of 4-
	   5	  
	  
7 months (total of 6 to 9 months of treatment). It is very important that people under TB 
medication follow the treatment regimen without any lapses as it paves way for drug-
resistance strains of mycobacteria. TB caused by drug-resistant strain is very hard and 
expensive to treat. Such long treatment plans also come with their own downsides of 
which the major threat is development of drug-resistance strains of M. tuberculosis 
(12,13). Therefore, better understanding of human host-M. tuberculosis interaction and 
M. tuberculosis physiology is believed to be crucial to develop more efficient drugs 
against TB. 
 
Host-Pathogen interaction  
As discussed earlier, tubercle bacilli are capable of both active and dormant 
survival inside host macrophage cells. To establish infection M. tuberculosis possesses a 
plethora of virulence factors whose expressions are regulated with progressing infection 
state concluding with latent infection and/or an eventual resuscitation from dormancy. 
Invading M. tuberculosis comes face to face initially with macrophages and 
dendritic cells (DC). These two innate immune cells are able to recognize pathogen 
components through highly conserved pattern recognition receptors (PRRs), including 
Toll-like receptor (TLR) family players. This recognition initiates the activation of both 
DC and macrophage, leading to phagocytosis and internalization of the bacilli in the 
phagolysosome complex, where they undergo lysis. The DC and macrophages travel to 
the mediastinal lymph nodes, in order to present bacterial lipids and peptide antigenic 
determinants to CD4+ and CD8+ T cells via MHC-I and MHC-II, leading to T cell 
activation and clonal proliferation. These T cells return to the site of primary infection 
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along with the macrophages and secrete cytokines such as IFNγ, IL-12, and TNFα (14). 
There are many defense mechanisms adopted by M. tuberculosis to resist host 
immune responses. One mechanism is dependent on the inhibition of phagosome-
lysosome fusion inside infected macrophages. Without successful degradation by 
macrophage, the bacterium is able to adapt to intracellular conditions that can have two 
outcomes. One, where the infected macrophage is utilized as a home to replicate and 
releases more microbes that then infect other cells, and two, where the bacteria can shift 
to a metabolically inactive stage known as latency (15). It has been shown that 
mycobacterium prevents lysosomal maturation (lysosome-phagosome fusion) with the 
help of the eukaryotic type Ser/Thr kinase PknG (16,17). 
Despite the importance of latency in the epidemiology and pathology of 
tuberculosis, it is yet not fully understood how M. tuberculosis alternates between a latent 
state and active replicating state inside the host. To achieve latency, however, 
mycobacterium must be able to respond to specific host signals and regulate its 
metabolism and growth. For this, the M. tuberculosis genome contains a wide variety of 
signaling molecules including eleven "eukaryotic-type" Ser/Thr protein kinases. Our lab 
has been studying two of these kinases, PknA and PknB, and their substrate proteins. The 
PknA/B signal transduction network is essential for the survival of M. tuberculosis (18). 
In addition, some of their known substrates (such as Wag31 and proteasome) are also 
known to be essential. Thus, understanding the roles of these kinases and their substrates 
will provide important information regarding the disease process in tuberculosis and thus 
can aid in the development of potent TB drugs. 
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Cell envelope of Mycobacterium tuberculosis 
M. tuberculosis is a Gram-positive, aerobic, rod-shaped bacterium measuring 2 – 
4 µm in length. Its cell envelope has a complex structure made up of peptidoglycan, 
mycolic acid, and arabinogalactan that are highly hydrophobic (19). The success of M. 
tuberculosis as one of the deadliest human pathogens can be easily attributed to its cell 
envelope make-up as it is this unique protective layer in Mycobacterium that guard the 
cell against the host’s immune repertoire (20). Upon entry into the host system, the 
bacillus encounters several different cellular environments that it must adapt partly by 
changes in the cell envelope’s physical and chemical composition. These physiological 
variations in cell envelope contribute to changes in the host-pathogen immunologic 
interplay that in turn plays a part in the success of the pathogen. A lot of focus has been 
given to understand the cell envelope composition of M. tuberculosis in hopes to 
determine the physiology and the changes that occur during host-pathogen interplay (21). 
Studies have been aimed at identifying different components of cell envelope and 
antigens present on the bacterial surface or secreted by the bacterium to determine 
virulence factors associated with cell envelope (22).  
The chemical structure and composition of the mycobacterial cell wall and 
envelope have been extensively studied and reviewed (23,24). David Minnikin proposed 
the definitive model of the structural composition of the mycobacterial cell envelope in 
1982 (25) (Fig.1.2). In this model, the cell envelope is similar to the lipid bilayer where 
mycolic acids are covalently linked to the cell wall associated arabinogalactan layer in 
order to form the inner leaflet. This inner leaflet is found to have the lowest permeability 
to organic chemicals in comparison to overall cell wall. The outer leaflet of cell wall is 
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believed to contain extractable phospholipids, glycolipids, peptidolipids, and mycosides 
(25,26). The mycolic acids (MA) are long chain (C60-C90) fatty acids and comprise a 
core structure covalently attached to an inner complex of arabinogalactan and 
peptidoglycan (mAGP) (26). Mycolic acids accounts for ~ 60% of the dry weight of the 
bacillus. The highly complex meshwork architecture of peptidoglycan (PG) is 
accomplished by having repeating units of N-acetylglucosamine (GlcNAc) and N-
acetylmuramic acid (MurNAc) or N-acylglycolic acid (MurNGlyc) that is also cross-
linked to the arabinogalactan (AG) layer (27). The mycolic acids are also associated with 
other essential virulence factors, trehalose monomycolate (TMM) and trehalose 
dimycolate (TDM) (28). Apart from these elements, other lipid and glycolipid 
components form the cell wall framework also play a role in pathogenesis of the bacillus 
(29).  
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Fig. 1.2: The lipid cell wall composition of Mycobacteria and the structure of TDM. The 
arabinogalactan is associated with mycolic acid that forms a second membrane-like structure adjacent to 
the peptidoglycan-linked cell wall. Above arabinoglactan layer is a thick mycolic acid layer made of 
complex lipid profile containing trehalose monomycolate (TMM), trehalose and trehalose dimycolate 
(TDM). The outermost layer containing capsule-like material consists of lipopolysaccharide and protein 
lies on top of mycolic acid layer. This unique cell wall composition is a crucial aspect of mycobacterial 
resistance to several drugs used for treating TB infection. (Image taken from (30)). 
 
The extremely hydrophobic waxy surface of mycobacterial cells is formed by the 
transfer of mycolate to the arabinogalactan chains by a group of mycolyl transferase 
enzymes called fibronectin binding proteins (Fbp) that are also known as antigen 85 
complex (31). In M. tuberculosis, there exist four Fbp proteins (FbpA, FbpB, FbpC1, and 
FbpBC2), whereas M. smegmatis has five Fbp proteins (FbpA, FbpB, FbpC, FbpD, and 
FbpE) (32). Among these various types of Fbp proteins, FbpC2 contributes the most to 
the mycolic acid content of the cell wall in M. tuberculosis, and FbpA, apart from its role 
as trehalose dimycolate (TDM) synthesizing enzyme, has been suggested to be required 
for virulence (33,34). FbpB, which also has the mycolyl transferase activity, has been 
suggested to have a role in the pathogenesis of TB by disseminating within the host 
through fibronectin interactions on the mucosal surface and elevating expression of 
interferon-gamma leading to a reduced phagocytosis by monocyte-derived-macrophages 
(35). 
 
Signal transduction in M. tuberculosis 
 
The success of a pathogen depends on its capacity to quickly sense and adapt in 
the host in order to subvert the constantly varying hostile host environment. To support 
this aspect of an organism’s adaptive nature, proteins that are capable of sensing and 
transducing external and internal cues are essential. Protein kinases and their cognate 
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phosphatases are enzymes that perform the important role in this kind of signal 
transduction pathways by catalyzing reversible protein phosphorylation (36,37). Many of 
those protein kinases respond to an external signal by autophosphorylation of themselves 
and then relay the signal to substrate protein(s) by trans-phosphorylation. Depending on 
the type of signal transduction system and the kinase involved, phospho-modification can 
occur on different amino acid residues such as serine (Ser), threonine (Thr), tyrosine 
(Tyr), histidine (His), or aspartate (Asp) (36,38).  
In bacteria, two-component systems (TCS) and the ‘eukaryotic-type’ Ser/Thr 
protein kinases (STPKs) mediate signal transduction network. M. tuberculosis has eleven 
two-component systems and eleven STPKs (18). Bioinformatic analysis has revealed that 
TCS and STPKs are conserved to a varying degree across the genus Mycobacterium (39). 
In bacteria TCS typically comprises of a membrane-bound sensor protein kinase 
(histidine kinase) that senses a specific environmental stimulus and a response regulator 
protein that relays the cellular response. The sensor kinase undergoes 
autophosphorylation on histidine residue and subsequently modulates the function of 
response regulator by phosphorylating aspartic acid residues. TCS is commonly found in 
prokaryotes with some discoveries of their existence also in eukaryotes (40). In 
eukaryotes, however, STPKs and phosphatases constitute the canonical signal 
transduction systems. Until recently, it was believed that STPKs are specific to 
eukaryotes but sequence analyses of bacterial genomes have revealed that they are also 
present in prokaryotes including M. tuberculosis (41). The first STPK discovered in 
prokaryotes was in Myxococcus xanthus (42). 
Protein phosphorylation by STPKs occurs on Ser, Thr, or Tyr residue. STPKs 
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have sequence homology in their kinase domain, which is used to classify STPKs into 
various STPKs superfamilies (43). The kinase domain contains twelve highly conserved 
subdomains that fold into a typical bi-lobed catalytic core structure that hides the 
catalytic active site in a deep cleft sandwiched by the two lobes (18). The N-terminal lobe 
is smaller compared to the C-terminal lobe and functions to bind and orient the phospho-
donor ATP molecule. The bigger C-terminal lobe of kinase domain is involved in 
substrate binding and transfer of phosphate group (44).  
 
Structure and function of Mycobacterial STPK 
The M. tuberculosis STPKs contain nine kinases that have a transmembrane 
domains and remaining two soluble kinases (PknG and PknK) (45,46). These nine 
transmembrane kinases have an intracellular, N-terminal kinase domain that is linked to 
an extracellular, C-terminal sensor domain through a single transmembrane helix. The 
extracellular domain is predicted to interact with signaling ligands and is identified to be 
a folded structure in PknB, PknD, and PknE. For example, the extracellular sensory 
component of PknB has four PASTA (Penicillin-binding protein and serine/threonine 
kinase associated) domains. PASTA domains have low affinity toward beta-lactam 
antibiotics, possibly due to their similarity to their predicted natural ligand: stem peptides 
of peptidoglycans (47). Even though the sensor domain structure of PknB and PknD is 
solved, the various ligands that these kinases bind to are largely unknown (46,48). The 
kinase domain structures of PknB, PknD, PknE and PknG have been well characterized 
(45,49). 
Hanks et al. (1988) described in their elaborate review that the kinase domain in 
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STPKs consists of approximately 250 amino acid residues spanning 12 conserved 
subdomains (43,45,50). The catalytic kinase domains can be organized into evolutionary 
clades based on sequence homology between STPKs of M. tuberculosis and other 
mycobacterial species. PknA, PknB, and PknL belong to the first clade/clade I and are 
conserved across the mycobacterial genus. Clade II contains PknH, PknE,and PknD, 
whereas clade III includes PknF, PknI, and PknJ. Clade IV and V are represented by the 
soluble kinases PknK and PknG (51). Apart from sharing high sequence homology, the 
three kinases in clade I are suggested to share a common function in cell division and 
morphology regulation (51,52). The operon containing pknA and pknB also contains the 
lone Ser/Thr phosphatase gene, pstP, whose product is a substrate of both PknA and 
PknB in M. tuberculosis (53). The start and stop codons in this open read frame (ORF) 
overlap, suggesting that transcription and translation could be coupled, and that they 
could have similar expression levels (52). 
 Like eukaryotic STPKs, M. tuberculosis STPKs including PknA and PknB are 
activated by autophosphorylation of the activation loop (49,54). Autophosphorylation has 
been identified to occur on T172 and T174 residues in PknA that has been suggested to 
be important mechanism for activation of the kinase (49,54). Studies indicate, kinase 
domains are dimeric, with dimerization probably occurring due to extracellular ligand 
binding to the sensor domain. Additionally, it is predicted that dimerization of kinase 
domains could be a regulatory mechanism to conduct trans or cis autophosphorylation of 
the activation loop leading to a conformational change for the activation of the kinase 
(55-57). 
Phospho-proteome analysis in M. tuberculosis has led to the identification of a 
	   13	  
	  
large number of STPK substrates to be involved in cell division, morphology, and other 
important regulatory pathways. Kang et al. (2005) showed that pknA and pknB are 
expressed preferentially during exponential phase of growth and that overexpression of 
these two kinase genes results in growth and morphological defects in M. tuberculosis. 
They also showed that Wag31, a homolog of cell division protein DivIVA in other 
bacteria, is phosphorylated by PknA/B in vivo and in vitro and that its phosphorylation 
status determines cell shape in M. tuberculosis (52). Overexpression studies, especially 
with pknB led to reduced growth rate and viability of M. smegmatis that was not seen in 
the presence of kinase defective mutants. When pknA was overexpressed in M. smegmatis 
or M. bovis BCG, the cells appeared elongated with branched morphology. On the other 
hand, pknB overexpression in either mycobacterial species gave rise to bulging rods. Our 
lab has further provided evidence to suggest PknB phosphorylates Wag31, which then 
affects polar peptidoglycan synthesis and cell morphology (58). In another study 
conducted by Dasgupta et al. (2006) it was shown that PknA phosphorylated Penicillin-
Binding-Protein A (PbpA) that is known to play a role in cell wall synthesis (59). 
Furthermore, in vivo studies based on M. tuberculosis survival inside macrophage also 
provided evidence of PknB as an important factor for growth during macrophage 
infection (60). These in vitro and in vivo data implicate that PknA and PknB are key 
regulators of cell shape, cell division, and growth.  
 
Proteasome  
Cellular proteins in general have a limited life span and their degradation is 
controlled by several types of protein degradation units. Intracellular degradation of 
protein in eukaryotes is dependent on two processes, namely the lysosomal pathway and 
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ubiquitin-dependent proteasomal pathway. Functionally, the lysosomal dependent 
proteolysis is believed to be less selective, compared to the proteolysis governed by 
proteasomes (61). This selectivity of proteasome is attributed to the protein called 
ubiquitin that are covalently linked to proteins marked for degradation (62). The 
proteasome degrades these ubiquitinated substrate proteins in the cytosol and nucleus of 
eukaryotes. These ubiquitin molecules are recycled and reused for proteolysis of other 
proteins (62). Proteasomes have a cylindrical multi-layered organization called 20S core 
particle (CP) that is sandwiched by cap-like structures called 19S regulatory particles 
(RP) (63). The active site of the proteasome is hidden in the catalytically active 20S CP 
and the substrate recognition and delivery into the 20S CP is carried out by the ATPase 
containing 19S RP (64).  
Bacterial proteasomes were discovered only recently when the 20S proteasome 
was identified in Thermoplasma acidophilum (63,65). It was determined that proteasome 
is essential for this microbe’s in vitro growth under heat shock conditions (65,66). 
Archaea and several eubacteria belonging to the order Actinomycetales, such as the 
genera Streptomyces, Frankia, Rhodococcus, and Mycobacterium, also possess 20S 
proteasomes, but they seem to lack both 26S proteasomes and ubiquitin (67).   
Fig. 1.3 is a diagrammatic representation of the mycobacterial proteasome 
pathway. Unlike eukaryotic proteasome subunit organization, the bacterial 20S CP is 
made up of a single type of α-subunit and a single type of β-subunit (32,68). In M. 
tuberculosis, proteasome structural organization is predicted to be similar to that of 
Rhodococcus species (63). The β-subunits form two seven-membered ring structure 
stacked on top of each other, which then form the catalytic core of the proteasome; an N-
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terminal Thr in the β-subunit is the catalytic nucleophile (65).  The β-subunits is 
expressed as an unprocessed protein containing N-terminal pro-peptide that is cleaved 
when half-proteasome assemble into a holo-proteasome structure. On both sides of the 
double-stacked β-subunit are the seven membered α-subunit ring structures (Fig. 1.3). 
The proteasome assembly begins when an α-subunit ring structure interacts with a β-
subunit ring it leads to the formation of a half-proteasome. Apposition of two half-
proteasome leads to cleavage of β-subunit pro-peptide resulting in the formation of a 
catalytically active holo-proteasome complex (63). In addition to the 20S CP, M. 
tuberculosis also possesses proteasomal accessory factors. Mycobacterium proteasomal 
ATPase (Mpa) is similar in function to the 19S cap found in eukaryotes. Mpa functions to 
recognize and unfold proteasomal substrates via its N-terminal coiled coil domain. 
Recognition of proteasomal substrate occurs by tagging the target protein with 
prokaryotic ubiquitin-like protein (Pup) Proteasome accessory factor A (PafA) Pup is 
attached to lysine residue in proteasome target proteins with the help of the Pup ligase 
(69,70).  
	   16	  
	  
          
 
 
 
 
In contrast to most bacteria that lack proteasome, M. tuberculosis requires 
proteasome for optimal growth and long-term survival in vivo (71). When the genes 
encoding the M. tuberculosis core proteasome, prcB and prcA, were depleted by 
conditional silencing, it affected their growth on solid media and in vivo survival in mice 
but not in vitro in liquid culture (71). Studies done using mutants depleting proteasome 
and proteasome associated genes such as pafA and mpa also suggest that M. tuberculosis 
proteasome plays an important role in nitric oxide resistance and in persistence during 
chronic mouse infections. During nitric oxide resistance, proteasome system may be 
responsible for targeted removal of nitrosylated proteins (72). On the other hand, similar 
Fig. 1.3: Mycobacterial proteasomal pathway. In mycobacteria PafA is responsible 
for tagging the substrate protein with Pup for proteasomal degradation. Once 
pupylated, substrate protein is recognized by Mpa that also helps in its unfolding and 
entry into the catalytic core of 20S proteasome. Dop is another enzyme that can help 
in reversing the pupylation step so that the degradation Pup-tag is removed when 
deemed unnecessary. 
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proteasome depletion in M. tuberculosis increased survival in response to hydrogen 
peroxide stress, suggesting that lack of proteasome is beneficial to oxidative stress 
response in M. tuberculosis (71). In Chapter 2, I describe my work on how 
phosphorylation of the proteasomal subunits by PknA may play a role in oxidative stress 
resistance by causing a proteasome depletion effect. 
 
Fibronectin Binding Protein5 (Fbp) 
M. tuberculosis cell wall has unique characteristics that attribute to the 
impermeability of most antibiotics. For example, M. tuberculosis contains a large amount 
of lipids, glycolipids like mycolic acid, and arabinogalactan-lipid complex, as described 
above.  This robust and highly impermeable cell wall makeup is also known to play an 
important role in pathogenesis (73). Additionally, the genes that are responsible for their 
metabolism and transport are potential virulence factors that have been suggested as 
targets for drug design (74). 
Fibronectin-binding proteins (Fbp) are such enzymes responsible for the 
production of some of those hydrophobic cell envelope molecules (75). Three 
independent genes (fbpA, fbpB, and fbpC) encode those Fbp proteins in M. tuberculosis, 
M. leprae, and M. avium. In M. tuberculosis FbpA, FbpB, FbpC2 and FbpC1 (FbpD) 
comprise the Fbp complex. Except FbpC1, these proteins have dual functions in M. 
tuberculosis; 1) to synthesize trehalose dimycolate and arabinogalactan-mycolate 
components of the mycobacterial cell wall, and 2) to modulate the immune system during 
infection by binding to fibronectin (75).  
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The Fbp proteins are also the major secreted proteins found in the culture filtrates 
of all pathogenic mycobacterial species examined to date (76). These proteins have 
molecular weights ranging from 30 kDa to 34 kDa with approximately 40 residues at N-
terminal region processed when secreted as matured proteins (77). It has also been found 
that these proteins are not only secreted but also retained in the cell wall of M. 
tuberculosis (78,79). Their role appears to be redundant in that all of the Fbp complex 
members possess mycolyl transferase activity required for the biogenesis of trehalose 
dimycolate (TDM), a dominant structure necessary for maintaining cell wall integrity 
(Fig. 1.4). The significance of cell wall associated forms of the Fbp proteins is believed to 
be in fibronectin binding and in turn for the pathogenesis of the bacilli by promoting 
receptor mediated phagocytosis and adherence to mucosal surface (80). The role of 
completely secreted FbpB is not yet clear but it has been suggested to be involved in 
inducing cell-mediated and humoral immune responses in M. tuberculosis-infected 
patients at an early stage of the infectious process (81).  
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Fig 1.4: Trehalose Dimycolate synthesis pathway in M. tuberculosis. 1. Intracellular TMM is 
transported outside of cell with help of ATP and ABC transporter system.  2. Once outside, mycolic acid is 
transferred from the 6-OH of one molecule of TMM to the 6'-OH of another TMM molecule, forming 
trehalose and TDM. TMM and TDM are linked to arabinan in the arabinogalactan (AG) layer outside 
associated with peptidoglycan (PG) layer lying above plasma membrane (PM)(82).  
 
The three proteins of the Fbp family are expressed at a steady-state ratio of 3:2:1 
(FbpB:FbpA:FbpC). 30 kDa FbpB is the most highly expressed of the three, and is also 
the most secreted protein, responsible for almost 41% of the total extracellular protein in 
liquid culture (83). In addition, during macrophage infection of M. tuberculosis, FbpB is 
one of the most secreted proteins observed in phagosomal space and on the bacterial cell 
wall (77). Tang et al. (2008) and others have suggested the use of the 30 kDa major 
secretory protein of M. tuberculosis (FbpB) as a vaccine candidate. In another study, it 
was shown that guinea pigs infected with M. tuberculosis aerosols could be protected 
against TB by vaccinating them with the purified FbpB (84). In Chapter, I will describe 
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that FbpB is phosphorylated and the phosphorylation of FbpB may play an important role 
in modulating its secretion and enzymatic activity.  
 
Mycobacterial strains in my thesis work 
 
M. tuberculosis belongs to the family Mycobacteriaeceae and human TB is most 
often caused by M. tuberculosis strains, though cases have also been reported due to M. 
africanum and M. bovis infection (2). M. tuberculosis strains differ in phenotype and 
virulence, such as Beijing strain being highly virulent, mostly causing extra-pulmonary 
TB than other strains (85). In 1905, a H37 laboratory strain was isolated from the sputum 
of a 19-year old chronic pulmonary TB patient, that later dissociated into a virulent strain 
(H37Rv) and an avirulent strain (H37Ra) (86). It is only the virulent strain H37Rv that is 
capable of replication inside human macrophage although both the strains have been 
successfully cultured in vitro using appropriate media (87). There are genetic and 
phenotypic anomalies between H37Rv and H37Ra, and the major difference lies in a 
mutation in the phoP gene, which is important for survival and replication in the 
intracellular environment (88). In the last two decades H37Ra strain has been routinely 
used as a control in M. tuberculosis identification and investigation of its virulence and 
genetic properties (89). 
Apart from H37-strains, BCG and different clinical isolates are commonly used to 
study the pathogenesis of mycobacteria. M. marinum is also commonly used, as it is 
genetically very similar to M. tuberculosis as well as safer to handle than M. tuberculosis 
(90). Another avirulent species of mycobacteria that is commonly used as a model system 
is M. smegmatis. The M. smegmatis genome has at least 14 counterparts of 19 virulence 
genes of M. tuberculosis (91). Additionally, M. smegmatis shares over 2000 homologs 
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with M. tuberculosis. In this study, I have used both H37Ra and M. smegmatis as model 
organisms although most of the preliminary work is based on M. smegmatis data. This 
species is preferred as a model organism since it is non-pathogenic, faster growing with a 
doubling time of 2.5 hours and only requires biosafety level 2 laboratory. 
 
Scope and outline of dissertation 
My thesis study is aimed at understanding the function(s) of the two Ser/Thr 
kinases, PknA and PknB, in M. tuberculosis. In the current scenario of TB where one in 
ten latently infected person has a potential to develop active TB disease, there is an 
urgent need for improving existing and discovering more effective anti-TB drugs. To 
achieve this, drugs that specifically target latent or persister cells are an attractive field of 
research especially due to their possibility of preventing post-exposure TB reactivation. 
The prevalence of active TB is now at its peak in the world due to HIV-TB co-
infection. The bacillus with its ability to resist a variety of host lesions and evade immune 
surveillance has many researchers puzzled. To overcome such harsh in vivo conditions, it 
is generally believed the bacterium must rely on a variety of cellular factors such as cell 
wall components, host-pathogen signaling mechanisms including proteins kinases and 
their cellular substrates. In order to understand these complex cellular processes, my 
research has been focused on determining the role of two key signaling molecules PknA 
and PknB. The overarching hypothesis is that identification of substrates of PknA and 
PknB will lead to understanding of function(s) of these two kinases and could serve as 
potential drug target(s). In the following chapters, I present data to describe; (i) An in 
vivo approach to identify substrates of PknA and PknB, (ii) the role of proteasome 
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phosphorylation in H2O2 resistance in mycobacteria, (iii) an in vitro technique to identify 
potential substrates of PknA and PknB, and (iv) the role of FbpB phosphorylation.  
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Chapter 2 
 
 
In vivo search for substrates of PknA/PknB and role of proteasome phosphorylation 
in Mycobacterium tuberculosis 
 
The work in this chapter is accepted in Journal of Microbiology. 
 
Anandan T, Han J, Baun H, Nyayapathy S, Brown JT, Dial RL, Moltalvo JA, Kim 
MS, Yang SH, Ronning DR, Husson RN, Suh J, Kang CM (2014) Phosphorylation 
regulates Mycobacterial proteasome. 
 	  	  
Abstract  
 
Mycobacterium tuberculosis possesses eleven STPKs contributing to its complex 
and important network of signal transduction systems. Despite evidence suggesting their 
crucial role in several important biological pathways, the molecular mechanism by which 
they lead to the latency or the switch to actively replicating state is still unknown. In this 
chapter, I demonstrate an in vivo method to hunt for potential substrates of PknA/PknB. 
Previous studies based on whole proteome analysis using phospho-(S/T)Q antibody led to 
identification of two in vivo substrates (Rv1422 and Wag31) of these kinases. Here, I 
provide evidence for the in vivo phosphorylation of the proteasome by PknA and PknB 
using a proteomic approach, Western blot with a phospho-T antibody, and mass 
spectrometry analysis. Additionally, I show that PknA phosphorylation of unprocessed 
proteasome β-subunit (pre-PrcB) and α-subunit of the proteasome leads to assembly 
defect of the proteasome complex, which then contribute to mycobacterial resistance to 
H2O2. Finally, I show that H2O2 stress diminishes the formation of the proteasome 
complex in a PknA-dependent manner.  
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Introduction  
	  
Signal transduction pathways in many pathogens not only function as an adaptive 
response regulator, but also have implications in controlling virulence determinants (92). 
As the most ubiquitous post-translational modification, protein phosphorylation can 
modulate cellular activities such as protein function or subcellular localization, target 
proteins for proteolysis as well as modulate protein-protein interactions. Moreover, a 
single protein could be phosphorylated by more than one kinase depending on the desired 
cellular activity, thus paving the way for a range of combinatorial regulation at the post-
translational level (51). Therefore, knowing which kinases are stimulated during a 
specific response and which proteins are their targets are integral to deciphering the 
mechanism underlying a wide range of biological processes. To accomplish this goal, our 
lab has been studying two STPKs, PknA and PknB, by identifying and studying the 
function(s) of their substrates in M. tuberculosis (52). We are interested in these PknA 
and PknB particularly because our previous studies had suggested that these two kinases 
have regulatory function in cell wall synthesis and cell shape, thus implicating their 
possible association in latency and/or active replication processes (52). 
To determine the functions of PknA and PknB in M. tuberculosis, Kang et al. 
(2005) took a peptide-library screening approach to screen for phosphorylation-sequence 
preference, and found that PknA and PknB have a preference for phosphorylating a Thr 
(T) residue followed by Gln (Q) (52). In addition, by using a phospho-proteome analysis 
with anti-phospho-(S/T)Q antibody and mass spectrometry after over-expressing PknA 
and PknB, they identified two in vivo substrates: Rvl422 (a hypothetical protein) and 
Rv2145c (Wag31, a homolog of B. subtilis DivIVA). Purified PknA and PknB both 
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phosphorylated Rvl422 in vitro. On the other hand, PknA and PknB combined together 
maximally phosphorylated Wag31. PknA alone only weakly phosphorylated Wag31 and 
PknB could not phosphorylate Wag31 at all (52). Even though this initial search were 
successfully able to identify those two in vivo substrates, this approach was limited to 
only those proteins that had the phosphorylated TQ motif due to the phospho-(S/T)Q 
antibody being used. 
In this chapter, I will describe another in vivo method to screen for potential 
substrate(s) of PknA and PknB. This technique is based on in vivo screening for 
substrates that required overexpression of PknA and PknB and whole proteome analysis 
using 2-D SDS-PAGE, western blot with a phospho-T antibody, and mass spectrometry. 
Furthermore, I report the phosphorylation of the M. tuberculosis proteasomal subunits by 
the PknA and PknB kinases. I determined that PknA phosphorylates unprocessed β-
subunit (pre-PrcB) and α-subunit, which then affects proteasome assembly and renders 
mycobacterial cells more resistant to H2O2. My finding thus suggests that 
phosphorylation of the proteasome by PknA/B contributes to the survival of M. 
tuberculosis under oxidative stress conditions.  
 
Results 
 
1. In	   vivo	   approach	   to	   search	   for	   the	   substrates	   of	   PknA/PknB	   in	   M.	  
tuberculosis	  
To further understand the role of PknA and PknB kinases, we attempted to 
identify their additional substrates by a similar in vivo proteomic approach, but with a 
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phospho-T antibody, instead of phospho-(S/T)Q antibody (Fig.2.1). To do this, M. 
tuberculosis H37Rv cells over-expressing pknA, pknB or vector alone were cultured in 
the presence of acetamide to induce kinase genes. Cells were harvested after 24 hr of 
induction and the whole proteome was purified. Whole proteome was separated using 
2D-PAGE, followed by partial transfer on to PVDF membrane and immunoblot with 
phospho-T antibody. The residual proteins in 2D-PAGE gels after partial transfer were 
subjected to a flamingo staining. Approximately 15 protein spots were found to be 
stronger in pknB-overexpressing M. tuberculosis than the vector-only control (Fig. 2.1). 
	    
 
 
 
 
 
Vector'
pknA''overexpression'
pknB&overexpression'
 
Fig. 2.1: In vivo approach to identify additional substrates of PknA and 
pknB. Whole proteome analysis of M. tuberculosis cells overexpressing pknA or 
pknB by 2D-Western Blot using phospho-T antibody. Upper panel: Vector only, 
middle panel: pknA over-expression, bottom panel: pknB over-expression. Mass 
spectrometry analysis of a spot (dotted red circle) in the pknB over-expression 
sample suggested PrcA to be phosphorylated at T84 and T202 residues. A weak 
spot of PrcA phosphorylation was also visible (red circle) in vector and pknA 
over-expression samples. 
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Mass spectrometry analysis of a spot from pknB-overexpression cells (dotted red circle, 
Fig. 2.1) revealed PrcA (α-subunit of the M. tuberculosis proteasome) as a potential 
substrate of PknB with two phosphorylation residues (T84 and T202). In this report, all 
the genes and proteins for kinases (PknA and PknB) and proteasome (PrcA and PrcB) are 
from M. tuberculosis unless otherwise indicated.  
The presence of a weak but distinct immunoblot signal at the similar location in 
cells with vector alone or pknA-overexpression (red circle, Fig. 2.1) suggests that PrcA is 
a physiologic target of PknB in vivo. However, as overexpression of kinase genes can 
lead to non-specific targets being phosphorylated, I conducted a confirmatory experiment 
to test whether PrcA is phosphorylated even without pknA-overexpression. For this, wild-
type M. tuberculosis was cultured in 7H9 liquid medium to mid-log phase where the 
kinase gene expression is known to be the maximum, and total lysate protein was 
subjected to 2D SDS-PAGE followed by western blot analysis, first with a phospho-T 
polyclonal antibody and subsequently with a PrcA polyclonal antibody after striping off 
the phospho-T antibody (Fig. 2.2). Superimposition of the two images revealed that PrcA 
(pI=5.19, MW=26.9; bottom panel) from M. tuberculosis cells without pknB-
overexpression appeared to be phosphorylated (upper panel).  
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2. Phosphorylation of PrcA (α-subunit of the proteasome) by PknB in vitro  
 
  To study the role of phosphorylation of the proteasome subunit PrcA by PknB, 
Seeta Nyayapathi and Jae-il Han in our lab conducted further investigation. For this they 
transformed wild-type M. smegmatis with pMH94-strep-prcA (pCK206), and the 
expression of strep-prcA was induced by 0.2 % acetamide for 4 hr at mid-log phase. To 
examine the phosphorylation of PrcA in vitro, strep-tagged PrcA was affinity purified 
using Strep-Tactin Affinity Purification Kit (Novagen). Affinity purification of strep-
PrcA afforded co-purification of PrcBMs, the β-subunit of the M. smegmatis proteasome, 
in approximately equimolar amounts (bottom panel, Fig. 2.3). This complex of PrcATB 
and PrcBMS, termed “chimeric proteasome” exhibited proteolytic activity against a 
Phospho&T(Antibody(
PrcA(Antibody( 37(KDa((25(KDa(
Fig.2.2: PrcA phosphorylation without pknB-overexpression in M. tuberculosis. 
Wild-type M. tuberculosis (attenuated mc26230 strain) cells was cultured and whole 
cell lysate was prepared for 2D-Western Blot using phospho-T antibody followed 
by stripping and re-probing the same blot with a polyclonal PrcA antibody. 
Confirming that PrcA is still phosphorylated under PknB non-overexpression 
conditions in vivo in M. tuberculosis. 
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fluorogenic substrate Suc-LLVY-Amc (93), indicating that PrcA forms an active 
proteasome complex with PrcBMs in M. smegmatis (data not shown).  
 
  
 
 
 
When incubated with [γ-32P]ATP, strep-PrcA was specifically phosphorylated by 
PknB but not by PknA (lanes 1 and 3, Fig. 2.3). Interestingly, PrcBMs from M. smegmatis 
was also phosphorylated by PknA and PknB (lanes 1 and 3, Fig. 2.3), suggesting that 
PrcB in M. tuberculosis may also be phosphorylated by one or both of these kinases. To 
validate the phosphorylation of PrcA in vivo, Jae-il examined the phosphorylation of 
strep-PrcA in the presence of pknB-overexpression in M. smegmatis. He purified strep-
PrcA from cells with or without pknB-overexpression and analyzed by 2-D Western 
blots, first with a phospho-T antibody and subsequently with a strep antibody after 
PrcATB PrcBMs 
Autoradiograph 	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Fig. 2.3: In vitro phosphorylation of PrcA by PknB. Chimeric complex of strep-PrcA 
and PrcBMs was incubated with GST-PknA, GST-PknB, or kinase-inactive mutant 
protein (GST-PknAK42M or GST-PknBK40M) in the presence of [γ-32P]ATP followed 
by SDS-PAGE, Coomassie blue staining (bottom row), and autoradiography (upper 
row). 
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striping off the phospho-T antibody. Mass spectrometry was performed on spots that 
were suspected to be phosphorylated and the results revealed PrcA to contain a third 
phosphorylation site at T178 in addition to the already identified T84 and T202. Jae-il 
also later demonstrated that PknB phosphorylated these three threonine residues in a 
sequential manner (T84, T202, 1178), and that PrcA phosphorylation is functionally 
important in regulating its proteolytic activity against a known substrate Ino1.  
Note: The work described henceforth describes my results leading to the 
identification of phosphorylation of Pre-PrcB and PrcA by PknA and its implications in 
H2O2 resistance in M. tuberculosis. 
 
3. PknA affects proteasome integrity in M. smegmatis 
Since we found that PrcBMs from M. smegmatis was phosphorylated by PknA in 
vitro (Fig. 2.3), I wanted to investigate if PknA can also phosphorylate M. tuberculosis 
PrcB. To do this, I expressed prcB-prcA-strep in the ΔprcBA M. smegmatis strain over-
expressing pknA, purified PrcA-strep to co-elute PrcB and examine its phosphorylation. 
To our surprise, PrcB was not co-eluted with PrcA-strep (lane 2, Fig. 2.4). In contrast, 
PrcA-strep purification from the ΔprcBA M. smegmatis strain overexpressing pknB (lane 
1) or containing vector alone (lane 3) co-purified PrcB (lane 1 and 3) as shown in Fig 2.4. 
This result suggested that pknA-overexpression may affect the proteasome assembly or 
make the proteasome complex unstable (lane 2, Fig. 2.4).  
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 To further analyze the levels of processed and unprocessed PrcB in these samples, 
I used 2D-PAGE and loaded more of the protein sample (15 µg) per gel in order to 
reassess the presence of PrcB in the purified proteasome samples. By loading more of the 
purified proteasome sample on 2D-PAGE and flamingo staining the gel, I was able to 
visualize processed and unprocessed PrcB along with PrcA (Fig. 2.5). Compared to the 
sample from the pknB-overexpressing cells, both pre-PrcB and processed PrcB levels 
were very low when pknA is over-expressed, indicating a possible role of PknA in 
processing of PrcB thereby affecting assembly or the stability of the proteasome complex 
(Fig. 2.5). In addition, the total amount of PrcA-strep plus PrcB purified from M. 
smegmatis expressing pknA was 5 to 10 fold lower than that of pknB-expressing or vector 
alone cells (data not shown) so that I had to load more volume of purification elution 
from the pknB-overexpressing cells to achieve the gel picture presented here. This result 
pre-­‐PrcB	   PrcA	   
pknB	  	  	  	  	  	  	  	  	  	  	  	  pknA	  	  	  	  	  	  	  	  	  	  	  	  vector 	   	  
Over-­‐expression 
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  2	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  3 
Fig. 2.4:  PrcB is not co-eluted with PrcA under pknA overexpression. 
Purification of PrcA-strep and co-elution of PrcB was analyzed using a 1-
D SDS-PAGE and Gel code blue staining. Approximately 5 µg of protein 
was used for each lane. Lane 1: purified PrcA-strep and co-eluted PrcB  
from cells with overexpression of pknB, lane 2: purified PrcA-strep 
without PrcB co-elution from cells with overexpression of pknA, lane 3: 
purified PrcA-strep and co-eluted PrcB from cells with vector alone. 
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suggests that, once again, PknA may affect the proteasome assembly or the stability of 
the proteasome complex. 
 
 
                      
                  In order to investigate whether the lack of the co-eluted PrcB in the pknA-
overexpressing strain is due to direct effect of PknA on proteasome, I conducted a second 
round of analysis in E. coli. E. coli was chosen for this experiment because it lacks the 
proteasomal system as well as PknA/PknB kinases, and therefore can provide an 
environment for a direct measure of PknA effect on proteasome integrity. As before, 
recombinant PrcA-strep was purified from E. coli expressing pknA or pknB, and co-
elution of PrcB was examined in 1-D PAGE. Fig 2.6 shows that while the formation of 
holo-proteasome was unaffected by pknB-expression, pknA-expression resulted in a 
mixture of half-proteasome (pre-PrcB + PrcA) and holo-proteasome (PrcB + PrcA), 
suggesting that PknA affects the processing of PrcB during the assembly of holo-
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Fig. 2.5: PknA affects the integrity of the proteasome core complex in 
mycobacteria. Proteasome purified from M. smegmatis containing pknA- or pknB-
overexpressing constructs was analyzed using 2D-PAGE and flamingo staining. Top 
panel: purification from cells with pknB, bottom panel: purification from cells with 
pknA. PrcA-strep (dotted box), pre-PrcB (dotted red circle), and processed PrcB (red 
circle) are shown. 	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proteasome. Taken together with the results from M. smegmatis, E. coli experiments 
suggest that this effect of PknA is probably via directly phosphorylating PrcB or PrcA 
because E. coli lacks both a PknA homolog and the proteasomal system. 
       
4. PknA phosphorylates both PrcA and pre-PrcB 
As the E. coli experiment in Fig. 2.6 suggests a probable direct effect of PknA on 
proteasome integrity, I hypothesized that PknA exerts this effect on the proteasome via 
directly phosphorylating proteasome subunit(s). To test which proteasomal subunit(s) 
is/are phosphorylated by PknA, the mixture of PrcA-strep and PrcB purified from E. coli 
expressing pknA was analyzed using immunoblot with phospho-T and strep antibodies 
(Fig. 2.7). Strong phospho-signals were found from pre-PrcB and PrcA but not from 
processed PrcB (lane 1, Fig. 2.7), suggesting that PknA phosphorylates the half-
proteasome and thereby may regulate its assembly into the holo-proteasome. 	  
 	  
Pre-­‐PrcB	   PrcA	   PrcB	   1	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  2 
	  	  	  	  	  	  pknA	  	  	  	  	  	  	  	  pknB	  	  	  	  	  	  	  	  	  	   Over-­‐expression 	  
Fig. 2.6: PknA affects proteasome integrity in E. coli. E. coli cells 
expressing prcBA-strep in the presence of pknA, pknB was used and PrcA-strep 
was purified using strep affinity column, and co-purification of PrcB was 
tested. As in M. smegmatis, pknA-overexpression led to decreased level of 
PrcA-PrcB and therefore 5-10 times more of elution from PknA-expressing 
cells was loaded than those of PknB-overexpression to achieve similar 
intensities of PrcA. 	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   To identify residues phosphorylated in pre-PrcB and PrcA by PknA, I conducted 
the following experiment in M. smegmatis expressing pknA. The ΔprcBA M. smegmatis 
strain that constitutively expresses prcBA-Strep and pknA was cultured with 0.2% 
acetamide for 7 hours. The cells were harvested in order to purify recombinant PrcA-
strep and PrcB using Strep column. Purified sample was dialyzed and subjected to 2D-
PAGE analysis, visualized using Flamingo stain and PrcB spots were cut out and 
analyzed by mass spectrometry. Mass spectrometry revealed that PrcA is phosphorylated 
at T195 and PrcB at T239. To test if these phospho-sites are correct, I made PrcAT195A 
and PrcBT239A mutants by site-directed mutagenesis, and tested their phosphorylation 
by using western blot with a phospho-T and a strep antibody (lane 2 and 3, Fig. 2.8). 
Briefly, the ΔprcBA M. smegmatis strain that constitutively expresses prcBA or prcB-
prcAT195A or prcBT23A9-prcA and contains pknA was cultured with 0.2% acetamide for 
7 hours. Cells were harvested, proteasome was purified using Strep-column, and 
1	  	  	  	  	  	  	  	  	  	  	  	  2	  	  	  	  	  	  	  	  
Pre-­‐PrcB	   PrcA	   
PrcB	   
Phosph
o-­‐T	  Ab
	   
Strep	  A
b	   
Fig. 2.7: Pre-PrcB and PrcA are phosphorylated by PknA. Purified 
PrcA-strep and co-purified PrcB in the presence of pknA-overexpression 
in E. coli BL21 (DE3) was analyzed using western blot with a phospho-
T antibody (lane 1) or a strep antibody (lane 2). 	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phosphorylation of each phospho-mutant form was analyzed by immunoblot with 
phospho-T antibody. 	  
 
 
 
 
 
 
 
 
 
 
Fig. 2.8 depicts the result of the phospho-mutant analysis, where both the 
phospho-ablative (T to A) mutants have lost most of phosphorylation (lanes 2 and 3, Fig. 
2.8) while wild-type proteasome showed phosphorylation of both pre-PrcB and PrcA. 
Protein loading was comparable in each sample as shown from the bottom western with a 
strep antibody. While I still have to perform another control experiment that show the 
levels of pre-PrcB in each mutant purification, it appears that mutation of one phospho-T 
residue results in the abolition of phosphorylation in another residue, suggesting that 
pre-­‐PrcB	   PrcA	   
PrcA	   
phospho-­‐T	  Ab 
Strep	   1	  	  	  	  	  	  	  2	  	  	  	  	  	  	  	  3	  	  	  	  	  	  	  	  
pr
cB
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  +	  pknA
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cB
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39
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A	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A	  
+	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Fig. 2.8. Confirming phosphorylation site in Pre-PrcB and 
PrcA. Confirmation of proteasome phosphorylation sites. M. 
smegmatis cells overexpressing pknA was used to purify 
proteasome mutant  proteins PrcB/AT195A or PrcBT239A/A and 
analyzed by westerns with phospho-T and strep antibodies. 
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phosphorylation of these residues by PknA may be dependent on each other’s 
phosphorylation.  
 
5. PknA does not affect the proteasome stability 
Since the total proteasome level was decreased by pknA-expression in both M. 
smegmatis and E. coli (Fig. 2.4 and 2.5), it was also possible that PknA destabilized the 
half-proteasome and/or the holo-proteasome complex after the assembly. To test this 
possibility, 3 µM proteasome complex was incubated alone (lane 3, Fig. 2.9), with 1 µM 
GST-PknA (lane 4), or GST-PknB (lane 5) in the presence of 1 mM ATP for 2 hr at 37 
°C. Kinase alone controls (lanes 1 and 2) were also included.  
 
 
 
 
Proteins in each reaction were then separated on two native PAGE gels; one was 
stained with Flamingo Fluorescent stain to test the integrity of the proteasome complex 
and the other was used for enzymatic assay in an in-gel proteasome assay by incubating 
1	  	  	  	  	  	  	  	  	  2	  	  	  	  	  	  	  	  	  	  3	  	  	  	  	  	  	  	  	  4	  	  	  	  	  	  	  	  	  5	  	  	  	  	  	  	  
proteasome 
proteasome 
Native	  PAGE	  +	  Flamingo	  stain 
In	  gel	  proteasome	  assay 
PknA PknB PrcB/A + + -­‐ -­‐ -­‐ -­‐ -­‐ -­‐ + + -­‐ + -­‐ + + 
Fig. 2.9: PknA does not affect proteasome stability. To determine if 
PknA affect the stability of the holo-proteasome, proteasome purified 
from E. coli cells was incubated with PknA, PknB, or without any 
kinase in the presence of ATP followed by an in-gel proteasome assay. 
Duplicate of the same reaction was also used in a native PAGE and 
stained with Flamingo staining. 
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the gel with 100 µM Suc-LLVY-Amc for 30 min at 30 °C. Fluorescence from Amc 
released was analyzed by the ChemiDoc XRS system and Quantity one 1-D analysis 
software (Bio-Rad). Proteasome integrity or activity for the peptide substrate was not 
affected by the incubation with PknA or PknB (Fig. 2.9), suggesting that PknA affects the 
integrity of the proteasome before the assembly step into the holo-proteasome. 
As a control experiment, the activities of kinases used in Fig. 2.9 were determined 
by an in vitro kinase assay with purified PknA or PknB and Rv1422, a known substrate 
of these kinases. Kinase assay reactions were resolved on SDS-PAGE followed by 
immunoblot with phospho-T antibody (Fig. 2.10).  Fig. 2.10 confirmed that PknA and 
PknB were active as the substrate Rv1422 was phosphorylated only in the presence of 
PknA or PknB (lanes 1 and 2, Fig. 2.10). 
                         
 
 
 
 
PknA%+
%Rv142
2!
PknB%+
%Rv142
2!
Rv1422
!
PknA%or%PknB%%Rv1422%Phospho2T%Antibody!%
1%%%%%%%%%%%%2%%%%%%%%%%%3%
Fig. 2.10: Confirming the activity of PknA and PknB. To determine 
PknA and PknB are active, a kinase assay was performed using purified 
PknA and PknB along with a known in vivo substrate of these kinases 
called Rv1422. Kinase assay reactions run on SDS-PAGE followed by 
immunoblot with a phospho-T antibody.  
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6. Effect of the proteasome phosphorylation on oxidative stress resistance  
Previous studies demonstrated that depletion of the proteasome and the 
proteasome-associated proteins (Mpa and PafA) rendered M. tuberculosis more 
susceptible to nitric oxide but increased its resistance to H2O2 by about 2 - 3 fold (71,94). 
Since I found that pknA-expression diminished the holo-proteasome level (Fig. 2.4), I 
sought to determine whether pknA-expression also enhances mycobacterial resistance to 
H2O2. To test this possibility, I first examined if depletion of the proteasome causes a 
similar phenotype in M. smegmatis. To do this, the ΔprcBA M. smegmatis strain 
constitutively expressing prcBA or containing pUAB100 vector alone was constructed 
along with wild-type M. smegmatis containing vector. These cells were treated with 0 
mM or 4 mM H2O2 for 45 min and CFUs were determined.  
 Introduction of M. tuberculosis prcBA into the ΔprcBA M. smegmatis strain 
decreased the resistance to H2O2 as in M. tuberculosis (survival rate of ΔprcBA M. 
smegmatis was 75% higher than that of the mutant carrying prcBA-strep; p<0.038) 
(compare bar 1 and 2 in Fig. 2.11). In contrast to the results in M. tuberculosis, however, 
the survival of ΔprcBA M. smegmatis following exposure to H2O2 was almost identical to 
that of wild-type M. smegmatis, suggesting that the proteasome in M. smegmatis may 
have different physiological functions than that of M. tuberculosis, possibly reflecting 
their different habitats.	  (compare bar 2 and 3 in Fig. 2.11). 	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Even though the phenotype of proteasome depletion in M. smegmatis was 
different from the one in M. tuberculosis, this result provided us a tool to test whether 
pknA-expression can enhance resistance to H2O2 of ΔprcBA M. smegmatis carrying 
prcBA. To do this, I conducted another survival rate experiment where the ΔprcBA M. 
smegmatis cells expressing prcBA in the presence of pknA-, pknB-overexpression, or 
vector alone was treated with 0 mM or 4 mM H2O2 for 45 min and the relative survival 
rate was determined as described above. As a control, ΔprcBA M. smegmatis that 
contains only pknA-overexpression cassette without prcBA was also included.  
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e	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Fig. 2.11: Mycobacterial resistance to H2O2 is increased by absence of proteasome. 
ΔprcBA or wild-type M. smegmatis cells with constitutive prcBA expression or vector alone 
was treated with 0 or 4 mM H2O2 for 45 min and CFUs were determined. Relative survival 
rate was calculated by dividing CFU from 4mM H2O2 by CFU from 0 mM H2O2 sample 
after 45 min.  	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Fig. 2.12 shows that pknA-expression in the presence of prcBA confers 67% 
higher resistance to H2O2 than cells containing vector only (p<0.012) (compare bar 2 and 
1). Though the percent change seems modest, the increased resistance to H2O2 by pknA-
expression was statistically significant and was obtained consistently over three 
independent experiments. In contrast, co-expression of pknB and prcBA did not change 
the resistance to H2O2 (compare 3 and 1, Fig. 2.12), consistent with the intact proteasome 
complex formation under pknB-overexpressing condition shown earlier in Fig. 2.4. In 
addition, pknA-overexpression alone (bar 4) did not change the bacterial survival rate in 
0 
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Fig. 2.12: Mycobacterial resistance to H2O2 is increased by pknA-expression.  ΔprcBA M. 
smegmatis cells expressing prcBA in the presence of pknA-, pknB-overexpression or pMH94 
vector alone was treated with 0 or 4 mM H2O2 for 45 min and the relative survival rate was 
determined as described in Fig. 2.11. As a control, ΔprcBA M. smegmatis that contains only 
pknA-overexpression cassette without prcBA was included. This result is a representative 
experiment of three replicates where each performed with triplicate plating. 
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the presence of H2O2, indicating that PknA contributes to H2O2 resistance mainly through 
the proteasome.  
  
7. H2O2 impedes the formation of holo-proteasome in a PknA-dependent manner 
If PknA increases the resistance to H2O2 via the proteasome, I predicted that H2O2 
stress would inhibit the formation of holo-proteasome in a PknA-dependent manner. To 
test this prediction, I wanted to examine the formation of the holo-proteasome under 
H2O2 treatment in ΔprcBA M. smegmatis that constitutively expresses prcBA in the 
presence of pknA- or pknB-expression (Fig. 2.13). For this, levels of PrcB processing 
were measured to examine the integrity of the holo-proteasome, by performing an 
immunoblot with a PrcB antibody.  
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  of	   Pre-­‐PrcB/Prcb 
Fig. 2.13: H2O2 affects Pre-PrcB processing. The ΔprcBA M. smegmatis strain that 
constitutively expresses prcBA (pCK322) and contains pknA- (pCK5) or pknB-expression 
(pCK7) were treated with 2 mM H2O2 for 1.5 and 4 hr. 20 µg total lysate protein from each 
culture was analyzed in immunoblot with a polyclonal PrcB antibody to test the processing of 
PrcB. 	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Two-fold more pre-PrcB was accumulated in cells expressing pknA after 1.5 hr 
H2O2 treatment (compare lanes 1 and 2, Fig. 2.13, upper panel), but not in cells with 
pknB-expression (lanes 3 and 4). Longer treatment of H2O2 dramatically diminished the 
level of both pre-PrcB and processed PrcB in pknA-expressing cells while processing of 
PrcB was near complete in pknB-expressing cells (Fig. 2.13, lower panel). Taken 
together, these data support that PknA plays an important role in oxidative stress response 
by impeding the formation of holo-proteasome. 
 
8. H2O2 affects holo-proteasome activity in M. tuberculosis 
 To further confirm the effect of H2O2 on the PrcB processing, I wanted to 
investigate whether in wild-type M. tuberculosis holo-proteasome formation and its 
activity is affected in the presence of H2O2. Wild-type M. tuberculosis cells were treated 
with 0 mM or 2 mM H2O2 for 24 hr. Cells were harvested and total lysate protein from 
each culture was analyzed by immunoblot with a polyclonal PrcB antibody. As shown in 
Fig. 2.14, exposure to H2O2 affects the processing of pre-PrcB and leads to defect in 
holo-proteasome formation in M. tuberculosis.  
 
              
Pre-­‐PrcB	   PrcB (processed)	   
H2O2(2mM) -­‐ + PrcB	  Ab (H2O2,	  24	  hr) 
Densitometric	  ratio	  of 	  Pre-­‐PrcB/PrcB 0.18	  	  	  	  	  	  	  0.91 
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T 
To analyze if this defect in holo-proteasome formation is reflected in its 
proteolytic activity as well, I conducted a proteasomal activity assay using whole cell 
lysate of wild-type M. tuberculosis that were treated with 0 mM H2O2 or 2 mM H2O2. 
Proteolytic activity was tested against a peptide substrate (Suc-LLVY-AMC). 
Fluorescence emitted by cleaved Amc was measured in a fluorometer at λex = 340 nm, 
λem = 460 nm (Fig. 2.15) as describe earlier. Proteolytic activity was absent in the cell 
lysate prepared from cells incubated with H2O2 but seen in control without H2O2 
treatment (Fig. 2.15).  These experiments provided clues that processing of PrcB in M. 
tuberculosis was also greatly retarded by H2O2 treatment thereby causing defects in holo-
proteasome formation and proteolytic activity in M. tuberculosis (Fig. 2.14 and Fig. 
2.15). Fig. 2.14 suggests that there may be some holo-proteasome formed even in the 
presence of H2O2 although the proteolytic activity tested of that lysate in Fig. 2.15 does 
not indicate that the holo-proteasome is proteolytically active. One possibility could be 
that oxidative stress leads to phosphorylation of the proteasome by PknA that not only 
leads to defects in integrity but also on the proteolytic activity of the holo-proteasome. 
oxidative stress conditions. 
 
Fig. 2.14: H2O2 impedes the formation of holo-proteasome in M. tuberculosis. M. 
tuberculosis mc26230 was cultured to log phase and treated with or without 2 mM H2O2 for 24 
hr. 20 µg total lysate protein from each culture was analyzed in immunoblot with a polyclonal 
PrcB antibody. The ratio of pre-PrcB to PrcB was determined as in Fig. 2.11.	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9. H2O2 activates PknA 
So far, my data suggest an important role of PknA in H2O2 resistance via 
proteasome but the mechanism underlying this process was not answered. To pursue this 
goal, I wanted to know whether H2O2 could activate PknA that then could lead to defects 
in proteasome integrity and H2O2 resistance. For this, E. coli BL21 (DE3) containing a 
pGEX-4T-3-pknA plasmid was cultured in the presence of 0.5 mM IPTG for 6 hr, and 
then exposed to 2 mM H2O2 for 0, 60, and 120 min. The levels of the PknA 
phosphorylation and the GST-PknA protein were determined by immunoblot with 
phospho-T (row 1, Fig. 2.16) and GST (row 2, Fig. 2.16) antibodies, respectively. Fig 
2.16 shows an increase in autophosphorylation levels of PknA in cells incubated with 
H2O2 with increasing incubation time, suggesting that PknA can be activated by H2O2. 
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Fig. 2.15: Presence of H2O2 affects proteasomal activity in M. tuberculosis. M. tuberculosis 
cells were harvested and lysate was used for a proteasomal activity assay. Lysates were treated 
with 2mM H2O2 and as controls lysate without H2O2 or blank containing no lysate were used. 
X-axis: Time (minutes), Y-axis: Relative Fluorescence Units (RFU). 
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This result is similar to that seen in the IkB kinase (inhibitor of NF-kB kinases) of some 
eukaryotes, where H2O2 has been shown to promote autophosphorylation of IkB kinase 
by phosphorylating two serine residues on activation loop thereby activating the kinase 
(95). Taken together, these data suggest that PknA plays an important role in the 
oxidative stress response by impeding the formation of holo-proteasome in M. 
tuberculosis. 
  
 
Discussion 
In this work, I determined that proteasome subunits, pre-PrcB and PrcA, are 
phosphorylated by PknA and that their phosphorylation enhances the resistance against 
H2O2 stress in mycobacteria. Together with the holo-proteasome assembly defects, H2O2 
resistance, and activation of PknA data presented here, these results indicate that PknA 
plays an important role in regulating proteasome integrity, oxidative stress response, and 
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Fig. 2.16: Autophosphorylation of PknA increases in response to H2O2. E. coli BL21 
(DE3) containing a pGEX-4T-3-pknA plasmid (pCK3) was cultured in the presence of 0.5 
mM IPTG for 6 hr, and then exposed to 2 mM H2O2 for 0, 60, and 120 min. The levels of 
the PknA phosphorylation and the GST-PknA were determined by immunoblot with 
phospho-T (row 1) and GST (row 2) antibodies, respectively. Densitometric ratio of the 
phosphorylation level and the GST-PknA level was determined as in Fig. 2.11. 
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possibly pathogenesis in mycobacteria. Fig. 2.17 describes a model speculated based on 
my findings of role of proteasome phosphorylation in increasing resistance to H2O2. 
 
 
 
In prokaryotes, genes encoding putative 20S proteasome are found only in the 
phylum Actinobacteria that mycobacteria belong to. Recently, phosphorylation of 
proteasome subunits (both α- and β-subunits) have been reported in eukaryotes and 
archaeal proteasomes (96,97). Phosphorylation was determined to enhance proteolytic 
activity against peptide substrates in eukaryotes (98). Here, I report that phosphorylation 
of mycobacterial proteasomal subunits (pre-PrcB and PrcA) by PknA affects the integrity 
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Fig. 2.17: Model for role of proteasome phosphorylation in M. tuberculosis (M. tb).  
Host induced defense factors such as H2O2 are made against an invading pathogen such as 
M. tb cells that are then available for them to activate PknA. Autophosphorylation of 
PknA results in activation of PknA and downstream substrate phosphorylation occurs on 
proteasomal subunits. This affects holo-proteasome integrity and thereby leading to a state 
of proteasome depletion that somehow leads to increased resistance to H2O2. 
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of the proteasome complex, via inhibition of processing of pre-PrcB and thus assembly 
into the holo-proteasome. Therefore, it is suggested that M. tuberculosis is able to 
modulate the levels of holo-proteasome complex through PknA whose activation is 
stimulated by H2O2. Phosphorylation of proteasome by PknA mimics a state of 
proteasome depletion that may then contribute to the pathogen’s higher resistance to 
H2O2 by possibly saving some unknown oxidative stress response proteins from 
proteolysis. I also present data to suggest that H2O2 activates PknA during H2O2 stress, 
and thus activated PknA become available to phosphorylate proteasome leading to rescue 
of bacilli in the presence of H2O2. Thus, these results could suggest a function of 
proteasome regulation by PknA to have a probable end result of establishing dormancy or 
persistence by M. tuberculosis.   
The pathogenesis of TB has been widely recognized as a tug-of-war between the 
pathogen and the host immune system. It is believed that once endocytosed by host 
macrophage, the bacilli has to encounter a robust supply of immune system molecules to 
overcome the stress and maintain dormancy or lead to active infection. One major 
defense mechanism seen with M. tuberculosis is reduced growth rate as a survival 
mechanism to fool the host immune system. Darwin et al. (2003) and Gandotra et al. 
(2007) have independently shown that lack of proteasome aids survival of M. 
tuberculosis against H2O2 stress (71,72). Consistently, I have found that PknA diminished 
the proteasome assembly that in turn led to increased resistance to H2O2, and that the 
H2O2 stress, via activating PknA, reduced the formation of the proteasome. What remains 
to be answered is how lack of the proteasomal system results in higher resistance to 
H2O2. M. tuberculosis possibly relies on PknA as a mode to sense the H2O2 stress at this 
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stage and affects the integrity of the proteasome, which may then lead to accumulation of 
oxidative stress proteins such as catalase-peroxidase (KatG) (99). Thus, it would be 
interesting to see if the integrity of KatG can be affected by proteasome and PknA. 
Another question is how H2O2 affects the proteasome assembly through PknA. It is 
known that in eukaryotes, several protein kinases (ERK [extracellular signal-regulated 
kinases] and MAP [mitogen-activated protein] kinases) are activated by H2O2 that serves 
as a survival mechanism against H2O2 exposure (95,100). Tabet et al (2005) showed 
MAP kinase activation through phosphorylation in the presence of H2O2 to be also 
increasing in a time dependent manner (95,100). Thus my results are in agreement with 
the MAP kinase activation by H2O2 seen in eukaryotes, as PknA autophosrylation level 
also seemed to increase when exposure time was increased in the presence of H2O2. In 
eukaryotes, IkB kinases (inhibitor of NF-kB kinases) is known to be activated by H2O2 
through phosphorylation of its activation loop at two serine residues (95). In this study I 
suggest a similar mechanism for the PknA activation in the presence of H2O2. Although 
the residue known to be target of autophosphorylation on PknA are T172 and T174; it 
will be important to confirm whether H2O2 promote phosphorylation of same residues 
(95). Further experiments to show whether activation of PknA can be inhibited in the 
presence of KatG can provide clues to the H2O2 induced stimulation of PknA 
autophosphorylation shown here. 
To better understand proteasome and its role in stress response, further studies 
focusing on determining how the phosphorylation of pre-PrcB and PrcA regulates the 
assembly of the proteasome complex would be crucial. We have yet to identify additional 
substrates of the PrcA-phosphorylated proteasome, and the molecular mechanisms by 
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which PrcA phosphorylation affect the substrate proteolysis. 
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Chapter 3 
 
 
In silico approach to search for new substrates of PknA/PknB, and  
role of FbpB phosphorylation 
 
 
Abstract  
 
The molecular switch between latency and active replication in M. tuberculosis is 
not greatly understood. It is speculated that precise regulation of cell wall biosynthesis 
must be a key mechanism to achieve transition between the two drastically varied growth 
stages. Therefore, to sense extracellular environment conditions protein-signaling 
cascades must act as messengers to relay information from outside to the inside of the 
cell. To investigate this possibility, I wanted to identify the role(s) of two eukaryotic-type 
Ser/Thr kinases, PknA and PknB by identifying and characterizing their substrates.  
Here, I describe an in silico homology approach to identify new substrates of 
PknA/PknB using the predicted preferred substrate phosphorylation motifs of PknA/B 
(ATQXIP or TQXIP, where X is any amino acid), and a synthetic peptide screening 
technique. Through this approach, I identified seven candidate substrate proteins. Of 
those seven candidate proteins, FbpB appeared to be of great interest because it belongs 
to a complex know as antigen 85 complex involved in the synthesis of cell wall 
component mycolic acid, an important virulence factor of M. tuberculosis. My work 
suggests that FbpB is phosphorylated in vivo in M. smegmatis and in M. tuberculosis, and 
that the 30KDa-secreted form of FbpB is dephosphorylated in M. smegmatis. Mass 
spectrometry analysis of the M. tuberculosis FbpB protein purified from M. smegmatis 
revealed 255T as a single phosphorylation site. The synthetic mycolyl transferase assay 
employed for assessing FbpB’s enzyme activity suggested that phosphorylation may 
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regulate its enzyme activity. The kinase responsible for FbpB phosphorylation is yet to be 
answered. 
 
Introduction 
Mycobacterium tuberculosis not only actively replicates during infection but also 
has a dormant intracellular phase where it has reduced metabolic activity and minimal 
cell division. This may account for the characteristic slow growth rate observed in M. 
tuberculosis, and could thus contribute to the ability of disease-causing members of 
mycobacteria to survive for long periods of time in animal hosts. While the molecular 
basis of the transition between these two completely different cell cycle phases is yet to 
be identified, it has been suggested that one key underlying mechanism must be in 
regulation of cell signaling in order to govern cell division and cell wall synthesis 
required for cell division.     
Previously, our lab showed that PknA and PknB phosphorylated preferably at the 
phospho-acceptor threonine (T) residue followed by glutamine (Q) at +1 position and 
hydrophobic residues at the +3 and +4 positions. Subsequent identification of the in vivo 
substrates (Wag31 and Rv1422) of these kinases demonstrated that those substrate 
proteins have a phosphorylation site that matches very well with the previous finding of 
substrate specificity (73TQAIP in Wag31 and 325TQEIP in Rv1422) (52). Further analyses 
of the preferred phosphorylation sequence for PknA/B against peptide library revealed 
that ATQXIP, (where X is any amino acid) is the consensus sequence preferred for the 
phosphorylation by PknA and PknB (52). In this chapter, I will describe an in silico 
method based on this consensus peptide sequence to screen for additional potential 
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substrate(s) of PknA and PknB, and investigate the role of phosphorylation of one such 
potential substrate, FbpB. 
 
Results 
 
1. Genomic search using a consensus peptide motif reveals 7 putative substrates of 
PknA/PknB 
Based on the preferred phosphorylation motif (ATQXIP) identified for PknA and 
PknB, I hypothesized that additional substrates of PknA and PknB have similar amino 
acid sequences around their phosphorylation site. Homology search for additional 
proteins containing the ATQXIP sequence in the whole M. tuberculosis genome resulted 
in no new protein except for the already identified substrates, Wag31 and Rv1422 (Fig. 
3.1).  
 
 Wag31 : GVTPQATQAIPAYE 
Rv1422 : EPPVAATQEIPIDG 
Search for proteins containing similar sequence in M. tuberculosis genome 
ATQXIP 
Wag31 
Rv1422 
TQXIP 
AceE (Probable pyruvate dehydrogenase E1 component)  
FbpB (Secreted Antigen 85-B) 
MbtB (Phenyloxazzoline synthase)  
Rv0940c (Possible Oxidoreductase)  
Rv1102c (PemK-like RNase toxin)  
Rv2743 (Conserved transmembrane protein)  
SugA (Probable sugar-transport integral membrane protein)  
Wag31 
Rv1422 
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However, a second round of investigation done by reducing the stringency of the 
consensus using TQXIP sequence revealed seven new candidate proteins that contain one 
or more of the potentially phosphorylated TQ motif. The list of candidate substrate 
protein is described in Fig. 3.2.All the peptides generated had MA residues at the amino 
terminus as a way to tag the peptides while verifying their sequence. The poly-lysine 
(KKK) tail at the carboxyl-terminus adds a net positive charge to the peptides at low pH 
thereby helping in their adsorption onto p81 phosphocellulose paper (101). 
	    
 
 
 
2. PknB maximally phosphorylates FbpB and Rv1102c in vitro  	  
In order to determine whether PknA and/or PknB phosphorylate any of these new 
substrate candidates, I synthesized a series of peptides that include the TQ motif and the 
1.  FbpB' ' 'MARNDPTQQIPKLVKKK ''2.  AceE ' 'MAEFRDTQRIPVSDKKK'3.  MbtB ' 'MASVLATQVVAGIRKKK'4.  Rv0904c 'MATPAPTQPIPILVKKK'5.  Rv1102c' 'MASCDNTQTIPVCDKKK'6.  SugA ' 'MASAPLTQQIPSLGKKK'7.  Rv2743c 'MATIAVTQAIPATLKKK'
Fig. 3.1: In silico search for putative substrates of PknA/PknB. Initial 
search with ATQXIP identified only Wag31 and Rv1422, however reducing 
stringency to TQXIP motif resulted in identifying 7 putative substrates of 
PknA/PknB. 
Fig 3.2: List of candidate proteins obtained from the in silico search for 
substrates of PknA/PknB. Each of the seven putative substrate proteins of 
PknA/PknB containing preferred phosphorylation motif highlighted in blue 
(TQXIP) was custom synthesized as 17-mer peptides for initial screening by in 
vitro phosphorylation. 
	   54	  
	  
surrounding residues of these proteins. All the peptides were synthesized as custom oligo 
peptides of 18mers with sequences spanning upstream and downstream of TQXIP motif 
(Fig. 3.2). To test if these peptides can be phosphorylated by PknA/B, I also needed to 
purify active PknA/B kinase proteins. The intracellular kinase domains of M. tuberculosis 
PknA and PknB were expressed and purified as fusion proteins with glutathione-S-
transferase (GST) tag from E. coli. As described before, a preliminary in vitro kinase 
assay was performed with Rv1422 to confirm their catalytic activity. Each synthetic 
peptide (200ng) was then subjected to in vitro kinase assay with PknA or PknB (200ng) 
in the presence of [γ-32P]ATP. The peptide of Wag31 was included as a positive control, 
along with peptide-only and enzyme-only as negative controls. The reaction was 
performed for two different incubation periods (20 and 40 min), and the incorporation of 
32P into peptides was measured using a scintillation counter. Fig. 3.3 shows that PknA 
highly phosphorylates the peptides of Rv0940c and SugA while PknB strongly 
phosphorylates those of Rv1102c, FbpB, and SugA, suggesting that PknA and PknB 
show specificity even with these short synthetic peptides.	  	  
 
	  
C
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Among these substrate candidates phosphorylated by PknA or PknB, I chose to 
further study FbpB (Fibronectin binding protein B) for the following reasons; 1) It is a 
member of a mycolyl transferase enzyme complex that is involved in the biosynthesis of 
trehalose dimycolate, a major cell wall components in mycobacteria, which contributes to 
the impermeable nature of mycobacterial cell wall and thereby their virulence, and 2) It 
interacts with extracellular matrix protein fibronectin and this interaction has been 
suggested to play a role in binding of tubercle bacillus cell to the mucosal surface and 
thus in the phagocytosis of the bacteria by the monocytes (80).  	  
3. FbpB is highly phosphorylated in vivo in Mycobacterium smegmatis 
 
 
  Since PknB phosphorylated the synthetic peptide of FbpB, I decided to further 
test whether PknB could also phosphorylate the FbpB protein in vitro. To do this, I first 
attempted to express the 6His-tagged fbpB gene in E. coli but this was not successful, 
probably due to difference in codon usage between E. coli and M. tuberculosis. 
Consistent with this, Kravchenko et al. (2007) showed that altering a few amino acid 
codons of FbpB resulted in high expression levels of FbpB in E. coli (102). As an 
alternative approach, I decided to express and purify M. tuberculosis FbpB from M. 
smegmatis. The M. tuberculosis fbpB gene was amplified by PCR with the C-terminal 
strep-tag and cloned behind an acetamide-inducible promoter in an integration vector 
Fig. 3.3: In vitro kinase assay with synthetic peptide of substrate candidates 
in the presence of PknA/B and [γ-32P]ATP. The yellow bars indicate the levels 
of phosphorylation in counts per minute for 200 ng of each peptide for 20 
minutes of reaction incubation time and green bars indicate the same for 40 
minutes of reaction incubation time. X-axis: Peptides; Y-axis: Counts per minute 
(CPM). Kinase assay reactions run using peptides labeled as follows; 1.FbpB, 
2.AceE, 3.MbtB, 4.Rv0940c, 5.Rv1102c, 6.SugA, 7.Wag31, 8.Rv2743c, 
9.Peptide only control; and 10.Kinase only control.  
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pMH94A (pMH94A-Pacet-fbpB-strep). This plasmid was then transformed into M. 
smegmatis and the recombinant FbpB-strep was expressed by adding 0.2% acetamide, 
and purified by using the Strep-Tactin affinity purification system (Novagen). Activity of 
PknB was tested by an in vitro kinase assay with the Rv1422 protein, a known substrate 
of PknB, where Rv1422 showed a high level of phosphorylation, suggesting that this 
PknB was an active enzyme (In the work presented in this dissertation, activity of both 
PknA and PknB has been confirmed for every in vitro kinase assay by this technique, 
data not shown). When this FbpB protein was incubated with PknB and [γ-32P]ATP, it 
showed very weak signal for phosphorylation (Fig. 3.4). The presence of other strong 
signals is a result of long exposure time for this autoradiograph. 
	  	  
	  37kDa	  	  
 25kDa 	  
Stained
	  
gel In	  vitr
o	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assay
	  
	  
PknB	  	  	  
 FbpB 
Fig. 3.4: Weak phosphorylation of FbpB purified from M. smegmatis by 
PknB in the presence of [γ-32P]ATP. Left panel shows Gel Code stained 
gel. Right panel is the autoradiograph for in vitro kinase assay.   	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  To obtain the signal intensity from FbpB shown in Fig. 3.4 (right column), I had 
to expose the gel for a long time and the signal from FbpB was even weaker than 
nonspecifically phosphorylated proteins (Left panel, Fig 3.4). One possible reason for this 
low level of radioactivity (phosphorylation) from FbpB was that FbpB was already 
phosphorylated in M. smegmatis before the purification. To test this possibility, I 
measured the phosphorylation of the FbpB protein without incubating with PknB by a 
Western blot analysis with a phospho-[S/T]Q antibody (Fig. 3.5). The FbpB protein 
revealed a strong Western signal, suggesting that FbpB had already been highly 
phosphorylated in M. smegmatis. Since there exists only one TQ motif in FbpB (T234), 
the synthetic peptide of FbpB was highly phosphorylated by PknB, and phospho-[S/T]Q 
antibody detected high level of phosphorylation in FbpB, I hypothesized that the 234T is a 
phosphorylation site. 
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4. Secreted FbpB is not phosphorylated in M. smegmatis 
Since FbpB is the second major secreted protein in M. tuberculosis after ESAT-6, 
I also wanted to determine if the secreted form of FbpB is also phosphorylated (103). To 
test this possibility, M. smegmatis cells containing pMH94A-Pacet-fbpB-strep was 
cultured in the presence of 0.2% acetamide until late log-phase, and intracellular FbpB-
strep was purified as described above. The secreted extracellular FbpB-strep was also 
purified by collecting the culture supernatant and precipitated total protein with 
ammonium sulfate (60%), and using the Strep-Tactin purification Kit. After dialysis, 
strep	  A
b	   
P [S/T]Q
	  Ab	   
FbpB 
Fig. 3.5: FbpB has been phosphorylated in M. smegmatis before 
purification. Western blot with a phospho-[S/T]Q antibody (lane 2) 
followed by stripping and re-probing with a strep antibody against Strep-
Tactin purified FbpB (lane 1),  
	   59	  
	  
approximately equal amount of the intracellular and extracellular FbpB-strep was 
subjected to a gradient SDS-PAGE (4 - 12%, Bio-Rad) to analyze by an immunoblot 
analysis with a strep antibody or a phospho-[S/T]Q antibody (Fig. 3.6). 
FbpB undergoes signal peptide processing, which leads to the removal of 40 
residues at the N-terminus during its secretion (77). In Fig. 3.6, we observed two major 
bands for FbpB-strep. While I plan to identify these bands by Edman degradation and 
mass spectrometry, predicted molecular weight of these bands are consistent with the 
processed form (the lower band with ~30 kDa) and the unprocessed form of FbpB (the 
upper band with ~34 kDa). Moreover, it is known that the secreted FbpB exists in two 
different forms, one as cell wall associated and the other as completely secreted into the 
extracellular environment (77). Consistent with this, I found both unprocessed and 
processed FbpB proteins from cell pellet (Intracellular, left column, Fig. 3.6) but mainly 
processed form of FbpB from supernatant (Extracellular, left column).  
	   	  
 
antibody) α*strep) Puri1ied)FbpB)
α*PTQ) Puri1ied)FbpB)
source) Intra*cellular) Extra*)cellular) Intra*cellular) Extra*)cellular)Total)protein)
µg)loaded) 5) 10) 5) 10) 5) 10) 5) 10)
)))))Unprocessed)FbpB))Processed)FbpB)
Fig. 3.6: Only intracellular FbpB is phosphorylated. 
Western blot with intracellular (CELL) and culture filtrate 
protein (CFP) of FbpB using a strep antibody followed by 
re-probing with a phospho-[S/T]Q antibody. 
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Interestingly, while both processed and unprocessed forms of intracellular FbpB 
were highly phosphorylated, the secreted FbpB did not show any phosphorylation 
(Intracellular and Extracellular, right column, Fig. 3.6), suggesting that the 
phosphorylation status of FbpB may be important for determining whether FbpB is 
attached to cell wall or completely secreted, or for processing and secretion processes of 
FbpB.    
To further confirm the phosphorylation status between the intracellular and the 
extracellular FbpB, I conducted a 2D western blot with protein samples used in Fig 3.6 
(Fig. 3.7). 200 µg of purified FbpB-strep was first rehydrated in a 2D strip (pH 4.7-5.9), 
and subjected to isoelectric focusing and 2D SDS-PAGE. First, a western blot was 
performed with a phospho-[S/T]Q antibody, and the membrane was stripped before 
probing with a strep antibody. Fig. 3.7 shows that most of the purified FbpB protein in 
the cell lysate is phosphorylated (Intracellular, Fig. 3.7), but after secretion there seems to 
be a loss of phosphorylation (Extracellular, Fig 3.7), confirming that the extracellular 
form of FbpB is not phosphorylated. 
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5. FbpB is phosphorylated in M. tuberculosis 
  To examine whether FbpB is phosphorylated in M. tuberculosis, the pMH94A-
Pacet-fbpB-strep construct was transformed into an attenuated M. tuberculosis mc26030 
strain and cultured in the synthetic Sauton’s minimal media for 3 weeks. Cells were 
further incubated for additional 3 days with 0.2% acetamide to induce the expression of 
FbpB-strep. Intracellular Strep-FbpB was purified using Strep-Tactin affinity column and 
subjected to western blot with a phospho-[S/T]Q and a strep antibody (Fig. 3.8). The 
FbpB-strep protein purified from M. tuberculosis showed processed and unprocessed 
FbpB, similar to those found in M. smegmatis. Western blot with a phospho-[S/T]Q 
antibody demonstrated the in vivo phosphorylation of FbpB purified from M. 
	  
α-
p
[S/T]Q 
pH 4.7-5.9 
Extracellular Intracellular 
	  
α-Strep 
Fig. 3.7. Different phosphorylation pattern between 
intracellular and extracellular FbpB. 2D-Western blot of 
intracellular and extracellular FbpB with a strep (top panel) and a 
phospho-[S/T]Q (bottom panel) antibody. 
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tuberculosis. This experiment also suggested that processing/secretion process for FbpB 
in M. smegmatis is similar to that of M. tuberculosis.  
 
	  	  	  	  
 
6. FbpB is phosphorylated at 255T 
 
With in vivo phosphorylation of FbpB in M. tuberculosis identified, I wanted to 
determine the actual site(s) of phosphorylation in FbpB. To do this, FbpB-strep purified 
from M. smegmatis was resolved using 2D-PAGE and desired spots were analyzed by 
mass spectrometry. Mass spectrometry analysis revealed a weak phosphorylation signal 
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  Ab	   p[S/T]Q	  Ab	   
	  
Fig. 3.8. FbpB is phosphorylated in vivo in M. 
tuberculosis. Western blot of intracellular FbpB 
from M. tuberculosis with a strep and a p[S/T]Q 
antibody. FbpB purified from M. smegmatis used as 
a positive control. 
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from 255T, but not from the predicted 234T (data not shown). This was disappointing, as 
255T did not represent the predicted phosphorylation site based on the motif TQXIP that 
was hypothesized to be the preferred phosphorylation motif for PknA/PknB. Upon 
analyzing the trypsin digest report for FbpB, I came to conclude that it’s possible that the 
peptide length spanning the 234T residue may not be the ideal ionization limit of mass 
spectrometry analysis. A second round of digest with chymotrypsin or other enzyme 
could be done to overcome this barrier and confirm the phosphorylation site in FbpB by 
mass spectrometry. 	  
7. Mycolyl transferase activity of FbpB is affected by phosphorylation 
Next, because FbpB is a mycolyl transferase, I wanted to test whether 
phosphorylation has any effect on its enzymatic activity. To measure the mycolyl 
transferase activity, I collaborated with Dr. Don Ronning group (at the University of 
Toledo, OH) by using an assay system they developed (104). I incubated the purified 
FbpB with p-nitrophenyl 6-O-octanoyl-β-d-glucopyranoside and β-glucosidase at room 
temperature and the rate of p-nitrophenolate production was measured as the absorbance 
at 405nm. A negative control was a reaction without FbpB. In addition, FbpC purified in 
Dr. Ronning group was included as a positive control since they used it to standardize the 
assay system.  
In Fig. 3.9 (A), wild-type FbpB purified from M. smegmatis shows mycolyl 
transferase activity, suggesting that this assay system can be used to test whether the 
phosphorylation of FbpB is involved in regulating the mycolyl transferase activity of 
FbpB. The right panel (B) in Fig. 3.9 shows the positive control assay performed with the 
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standardized FbpC enzyme (blue line) along with a negative control having no 
enzyme/blank reaction (red line). 
	  	  
Fig. 3.9. Mycolyl transferase assay. (A) Wild-type FbpB purified from M. smegmatis was incubated with 
the synthetic substrate and samples tested include; (blue line) WT FbpB purified from M. smegmatis and 
dialyzed against a buffer containing glycerol; (red line) WT FbpB purified from M. smegmatis and dialyzed 
against a buffer without glycerol; (yellow line) Blank;  (green line) WT FbpB purified from culture filtrate 
protein and dialyzed against a buffer without glycerol. (B) FbpC purified from E. coli used as a positive 
control for enzyme assay. Samples tested include (red line) No enzyme blank; (blue line) FbpC purified 
from E. coli. 	  
 
As I confirmed that wild-type FbpB-strep had mycolyl transferase activity in Fig. 
3.9, I wanted to test whether phosphorylation has any effect on its enzymatic activity 
using wild-type FbpB, phospho-ablative FbpBT234A and phospho-mimetic FbpBT234E. 
by using the assay system used in Fig.3.9. Fig. 3.10 (left panel) shows that FbpBT234A 
has lower mycolyl transferase activity than wild-type FbpB. However, a similar 
experiment with FbpBT234E and wild-type FbpB activity on right panel suggested 
almost similar activity of both these proteins, suggesting that phosphorylation could be 
enhancing mycolyl transferase activity of FbpB. In summary, although 234T is yet to be 
confirmed as a phosphorylation site in FbpB, it still seems to be an important residue in 
determining the mycolyl transferase activity in FbpB. 
! !
(A) (B) 
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Discussion	  
 
In this study, I demonstrated an in silico method to screen for potential substrates 
of PknA/PknB. This approach provides an opportunity to identify potential targets of 
PknA/PknB phosphorylation, and also to later characterize the substrate proteins so as to 
determine their regulatory function thereby identifying the role(s) of PknA/PknB in M. 
tuberculosis. The peptide library screen employs in vitro kinase assay using the STPKs- 
PknA and PknB that catalyze the transfer of the γ-phosphate of adenosine triphosphate 
(ATP) to substrate peptide’s thr residues.  
Previously, Kang et al. (2005) have shown that PknA and PknB predominantly 
phosphorylate at thr residues, with a strong phosphorylation motif preference for 
ATQXIP. In this work, it is interesting to note that PknA and PknB phosphorylate 
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Fig. 3.10: Phosphorylation might enhance mycolyl transferase activity. Wild type and 
FbpBT234A purified from E. coli subjected to enzyme assay. Left panel: FbpBT234A mutant 
showing lower activity than wild type FbpB. Right panel: FbpBT234E purified from E. coli shows 
higher activity as compared to FbpBT234A mutant. RFU value indicated for each sample here 
represents average of triplicate reactions. 	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different sets of peptides thereby suggesting their slightly different substrate specificity 
(52). Among the seven candidate peptide substrates, four of the peptides namely, FbpB, 
Rv0940c, Rv1102c and SugA showed highest level of phosphorylation by PknA/PknB. 
Rv0940c whose peptide was maximally phosphorylated by PknA, is predicted to be an 
oxidoreductase. Rv1102c is an mRNA interferase, with its peptide showing highest 
phosphorylation by PknB when compared to PknA. Further investigations on this protein 
led us to the finding that Rv1102c is part of a toxin-antitoxin system (Rv1102c-Rv1103c 
system) (105). Additionally, Dr. Jeong-Sun Han and I were able to demonstrate that 1) 
Rv1102c interacts with Rv1103c, 2) Rv1103c antagonizes the mRNA interferase activity 
of Rv1102c and thus acts as its cognate antitoxin, and lastly 3) the expression of Rv1102c 
is coupled to that of Rv1103c. The research paper titled ‘Characterization of 
chromosomal toxin-antitoxin, Rv1102c-Rv1103c system in Mycobacterium tuberculosis” 
was second authored by me and published in 2010 (105). SugA is part of an ABC 
transporter complex, whose role in virulence is highlighted by its specific function in 
trehalose uptake.  
Of the newly identified candidate substrate proteins, FbpB seemed to be of great 
interest as it belongs to a complex know as antigen 85 complex involved in the synthesis 
of cell wall component mycolic acid, which is one of the major virulence factors of M. 
tuberculosis. I have shown that FbpB is phosphorylated in vivo in M. smegmatis as well 
as in M. tuberculosis and that the 30 KDa secreted form of FbpB is not phosphorylated. 
Additionally, I also determined that in M. smegmatis intracellular FbpB is phosphorylated 
while the extracellular is not, suggesting a possible role of phosphorylation in its 
processing and/or secretion (Fig. 3.5). Based on this analysis, I investigated the role of 
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FbpB phosphorylation in its secretion by purifying secreted form of FbpB from M. 
smegmatis culture-filtrate and compared it with intracellular FbpB by western blot with 
phospho-[S/T]Q antibody. Furthermore, mass spectrometry analysis of FbpB purified 
from M. smegmatis revealed 255T as a single phosphorylation site in FbpB and currently 
this phosphorylation site needs to be confirmed. The synthetic mycolyl transferase assay 
employed for assessing FbpB’s enzyme activity suggested phosphorylation may reduce 
the mycolyl transferase activity of FbpB. Even though, mass spectrometry did not 
identify 234T as the phosphorylation site, phospho-mutants analysis suggests that the 
residue 234T is important for mycolyl transferase activity of FbpB. This data could thus 
suggest the reason for the apparent difference in level of mycolyl transferase activity seen 
between FbpB and the other members of the antigen 85 family; FbpA and FbpC. FbpB’s 
reduced mycolyl transferase activity could be due to the probable lack of 234T 
phosphorylation upon secretion since we know that secreted form and FbpBT234A had 
the least enzyme activity. 
The hydrophobic nature of mycobacterial cell wall confers passive resistance 
against chemicals, dehydration, and degradation by host factors, inactivation of reactive 
oxygen intermediate (ROI) and reactive nitrogen intermediate (RNI), and prevents entry 
of toxic anti-TB compounds and antibiotics into the cell (106,107). Careful regulation of 
the STPKs enables precise cellular responses to external signals, allowing bacteria to 
survive in a variety of changing environmental conditions. As discussed earlier, FbpB is a 
predominantly secreted protein forming the bulk of culture filtrate protein in 
mycobacteria that is predicted to play a role in internalization and adaptation of M. 
tuberculosis. The kinase responsible for FbpB phosphorylation and the role of FbpB 
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phosphorylation in host-pathogen interaction, for example in fibronectin binding, and 
pathogenesis are yet to be answered.  
In summary, I provide an in silico peptide library screening method to fish for 
PknA and PknB targets in M. tuberculosis, which could possibly be applied to screen for 
substrates of other kinases. Future work focusing on other two candidate substrates; 
SugA and Rv0940c could be tested in order to provide insight into the way these protein 
act as molecular switches that regulate diverse cellular event such as growth, 
development and pathogenesis by signaling molecules. The global urgency related to TB, 
which is currently the leading infectious disease causing the highest mortality, with the 
added potential of these proteins in regulating vital metabolic pathways, provide strong 
rationales for investigating the functions and mechanisms of the M. tuberculosis STPK 
signaling systems. 
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APPENDIX A 
 
EXPERIMENTAL PROCEDURES 
 
 
A.1. Culture conditions. 
H37Rv, mc26230 M. tuberculosis, and M. smegmatis MC2155 cultures were 
grown at 37 °C in Middlebrook 7H9 liquid medium (Difco) supplemented with 10% 
ADC [ADC = 5% (w/v) BSA fraction V powder, 2% (w/v) glucose and 0.85% (w/v) 
NaCl], and 0.05% (w/v) Tween-80, or on Middlebrook 7H9-ADC agar plates 
supplemented with 0.05% (w/v) glycerol. Kanamycin (50 µg/ml), hygromycin (50 µg/ml) 
or apramycin (50 µg/ml) was added to culture media where required. Escherichia coli 
DH5α (Invitrogen) was used as a cloning host, and E. coli BL21 (DE3) for expression of 
recombinant proteins. Cultures were grown at 37 °C in LB broth or solid medium with 
apramycin (50 µg/ml), kanamycin (50 µg/ml), chloramphenicol (34 µg/ml) or ampicillin 
(50 µg/ml) where appropriate.  
 
A.2. Plasmid construction 
 
For in vitro kinase assay of the chimeric proteasome complex, strep-prcA was 
PCR amplified using the genomic DNA of M. tuberculosis H37Rv and cloned into an 
integrating plasmid pCK202 driven by the acetamide-inducible promoter. All the primers 
used in Chapter 2 are listed in Table 2. This construct, named as pCK206 (All the 
constructs made are listed in Table 1), comprises the attachment site (attP) and the 
integrase gene (int) of mycobacteriophage L5 for integration (108,109). For in vivo 
phosphorylation analysis of PrcA in DprcBA M. smegmatis, prcBA-strep was PCR 
amplified by using primers TBprcBA pUAB100-F and TBprcBA-C-strep3', and cloned 
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behind a constitutive hsp60 promoter in a replicating plasmid, pCK315 (and named as 
pCK322). For testing the phosphorylation of WT and mutant forms of PrcA in E. coli, 
prcBA-strep was PCR amplified by using primers C-StrepTBprcB-5 and TBprcBA-C-
strep3', and cloned under T7 promoter in pACYCDeut-1 (Novagen) (named as pCK343). 
To construct a ∆prcBA M. smegmatis strain (KMS98), 5’- and 3’-flanking regions of the 
prcBAMs genes was amplified by PCR by using primers Dn-PrcA-F, Dn-PrcA-R, Up-
PrcB-F, and Up-PrcB-R, and the genomic DNA of WT M. smegmatis MC2155. The 
hygromycin resistance gene was inserted between the two flanking regions in pRH1351 
and named as pCK260.  
 For in vivo and in vitro kinase assay of the FbpB, strep-fbpB was PCR amplified 
using the genomic DNA of M. tuberculosis H37Rv. All the primers used in Chapter 3 are 
listed in Table 3, and cloned into an integrating plasmid pCK202 carrying an acetamide-
inducible promoter, and named as pCK206 (All the constructs are listed in Appendix A, 
Table 1). Plasmids expressing fbpBT234A and fbpBT234E were generated by using the 
QuickChange Site-Directed Mutagenesis Kit (Stratagene) with primers indicated in Table 
3.  
 
A.3. Protein expression, purification and analysis of recombinant proteins 
 
  To purify the chimeric proteasome complex, M. smegmatis KMS65 was grown to 
mid-log phase where expression of strep-prcA was induced by 0.2% acetamide for 4 hr. 
Strep-PrcA was purified by using the Strep-Tactin Affinity Purification Kit (Novagen). 
The M. tuberculosis proteasome complex for the in vivo phosphorylation was purified 
from ΔprcBA M. smegmatis carrying pCK322 plus pCK5 (KMS109), pCK7 (KMS108), 
or pMH94 vector (KMS157) by overexpressing pknB at mid-log phase with 0.2% 
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acetamide for 4 and 16 hr. A parallel flask without acetamide was also cultured for 16 hr. 
PrcA-strep was purified by using the Strep-Tactin Affinity Purification Kit (Novagen) as 
described above. To test the effect of PknA on proteasome complex formation in E. coli, 
pCK343 was transformed into E. coli BL21 (DE3) containing pCK3 or pCK4, which 
were cultured in Overnight Express Autoinduction medium at 37 °C for 10 hr, and PrcA-
strep was purified as described above. For 2-D PAGE, immunoblot, and mass 
spectrometry, total protein extraction from M. tuberculosis harboring pMH94 plasmid 
alone, pCK5, or pCK7 and subsequent 2-D SDS-PAGE were performed as described 
previously. For the in vivo phosphorylation of PrcA, 30 µg of each purified PrcA-Strep 
was similarly analyzed in 2-D SDS-PAGE with IPG strips of pH 4-7 (Bio-Rad). Then, 
Western blots were performed by a phospho-T antibody, and subsequently with a strep-II 
antibody (Novagen) after stripping off the first antibody by using a stripping buffer (100 
mM 2-mercaptoethanol, 2% (w/v) SDS, 62.5 mM Tris-HCl, pH 6.7) at 50 °C for 30 min. 
Mass spectrometry for the identification of the phosphorylation sites in PrcA was 
performed as previously described. To analyze the proteasome complex in M. smegmatis 
overexpressing pknA, 15 µg of PrcA-strep plus PrcB complex used in Fig. 3.5 was 
analyzed in 2-D SDS-PAGE with Flamingo Stain (Bio-Rad).  
For purification of FbpB-strep, and all the phosphomutants of FbpB used in 
Chapter 3 cells were grown to mid-log phase where expression of FbpB-strep was 
induced by 0.2% acetamide until stationary phase. FbpB-strep including all it phospho-
mutant proteins were purified by using the Strep-Tactin Affinity Purification Kit 
(Novagen). To purify extracellular FbpB, culture filtrate protein was isolated using 40% 
ammonium sulfate (AS) precipitation method. Mycobacterial cells expressing FbpB were 
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inoculated in modified Sauton’s medium and incubated at 370C until early stationary 
phase.The cultures were centrifuged at 16,000 g for 30 min at 40C and filtered through 
0.22µm Millex GV PVDF membrane (Millipore). The filtrate was later used for a 40% 
AS precipitation to isolate culture filtrate protein and purification of recombinant FbpB 
was carried out using strep affinity column (Profinia) as described before. 
 
 
A.4. In-gel proteasome assay 
3 µM proteasome complex purified from E. coli containing pCK343 was 
incubated with 1 µM GST-PknA or GST-PknB in the presence of 1 mM ATP in kinase 
assay buffer (50 mM HEPES, 50 mM NaCl, 10 mM MgCl2, 2 mM MnCl2) for 2 hr at 37° 
C. Reaction was stopped by adding Native Sample buffer (Bio-Rad), and proteins were 
separated on two native PAGE gels; one was used to visualize proteins by staining with 
Flamingo Fluorescent stain (Bio-Rad) and the other was used for an in-gel proteasome 
assay by incubating the gel in proteasome assay buffer (50 mM HEPES pH 7.4, 5 mM 
EDTA) and 100 µM Suc-LLVY-Amc (Boston Biochem) for 30 minutes at 30° C. 
Fluorescence from Amc released was analyzed by the ChemiDoc XRS system and 
Quantity one 1-D analysis software (Bio-Rad). Activity of PknA and PknB was tested in 
a parallel reaction that included 2 µM 6His-Rv1422, a known substrate of PknA and 
PknB, and its phosphorylation was analyzed in immunoblotting with a phospho-T 
antibody. 
 
A.5. H2O2 susceptibility assays 
 To examine the effect of the proteasome on M. smegmatis survival in the 
presence of H2O2, wild-type (KMS197) and ΔprcBA M. smegmatis strains (KMS128 and 
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KMS116) were cultured overnight in 7H9 medium (50 µg/ml hygromycin and 50 µg/ml 
apramycin), diluted to OD600=0.01 in 7H9 medium, treated with 4 mM H2O2, and 
incubated at 37 °C for 45 min. The cultures were serially diluted into a buffer containing 
0.8% NaCl and 0.01% Tween-80 and plated on 7H9 plates for CFU determination. The 
influence of pknA-expression on the survival in the presence of H2O2 was tested by using 
the ΔprcBA M. smegmatis strain constitutively expressing prcBA with induction of pknA, 
pknB, or vector (KMS108, KMS109, and KMS157) overnight in 7H9 containing 
hygromycin, apramycin, and kanamycin. As a control, ΔprcBA M. smegmatis carrying 
pknA-expression cassette alone (KMS201) was included. To induce the expression of 
kinases, overnight culture was diluted to initial OD600=0.05 and incubated with 0.1% 
acetamide for 5 hrs. To test for sensitivity to H2O2 cultures were further treated with 4 
mM H2O2 and incubated at 37° C for 45 min, followed by serial dilution to determine 
CFU.  
 
A.6. Effect of H2O2 on proteasome assembly and PknA phosphorylation 
  ΔprcBA M. smegmatis that constitutively expresses prcBA and contains pknA- 
(KMS109) or pknB-expression cassette (KMS108) was cultured with 0.2% acetamide for 
6 hr. Cells were then treated with 2 mM H2O2 for 1.5 and 4 hr. 20 µg total lysate protein 
purified with TRIzol was used for SDS-PAGE followed by Western blot with a PrcB 
polyclonal antibody. Autophosphorylation of PknA in response to H2O2 was tested in E. 
coli BL21 (DE3) containing a pGEX-4T-3-pknA plasmid (pCK3) cultured in the presence 
of 0.5 mM IPTG for 6 hr, and then exposed to 2 mM H2O2 for 0, 60, and 120 min. The 
levels of the PknA phosphorylation and the GST-PknA were determined by Western 
blottings with phospho-T and GST antibodies. 
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A.7. In vitro kinase assay 
 To test the phosphorylation of FbpB in vitro, FpbB-strep, FbpBT234A, GST- 
PknB, or Rv1422-his protein was incubated with strep-FbpB in 1X kinase buffer (50 mM 
Tris-HCl at pH 7.5, 50 mM NaCl, 10 mM MgCl2, 10 mM MnCl2) along with 1 µCi of [γ-
32P]ATP, and incubated at room temperature for 1 hour. Reactions were terminated by 
adding SDS gel-loading buffer and the proteins were resolved by 8% SDS-PAGE, 
followed by staining with GelCode Blue (Pierce). Gels were dried under vacuum with the 
help of Hoefer slab gel dryer (Model GD2000) at 65 °C for 3 hours before exposing to 
CL-XPosure film (Thermo Scientific). Phosphorylation of the phosphoablative forms of 
FbpB was examined by incubating of the proteasome complex containing FbpBTA with 
GST-PknB and 1 mM regular ATP. The relative phosphorylation levels of each protein 
were determined by immunoblot with either a phospho-[S/T]Q or phospho-T antibody 
and, stripped to be re-probed with anti-strep antibody or GelCode staining of parallel 
reactions.  
 
A.8. Mycolyl transferase assay 
To test the mycolyl transferase enzyme activity of FbpB and its mutant forms, a 
mycolyl transferase assay system developed by Dr. Ronning group (University of Toledo, 
OH) was used. For this, I collaborated with the laboratory of Dr. Donald Ronning 
(University of Toledo, Ohio) that has established an assay system to measure mycolyl 
transferase activity using synthetic substrates. Briefly, the system uses a synthetic 
substrate (100 µm), p-nitrophenyl 6-O-octanoyl-β-d-glucopyranoside that undergoes a 
nucleophillic attack on the ester linkage of the octanoyl moiety by the enzyme to release 
p-nitrophenyl β-d-glucopyranoside. This product of the first catalysis then serves as a 
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substrate for β-glucosidase that releases glucose and p-nitrophenolate the chromogenic 
product that is measured as absorbance at 405nm. For the mycolyl transferase assay, each 
protein sample used was approximately 1 µm. 
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APPENDIX B 
 
 
Table 1. Strains and Plasmids used in Chapter 2 
 
 
 
Strain 
 
 
Description 
 
Reference 
E. coli   
E. coli Top10 E. coli host for molecular 
cloning 
Invitrogen 
E. coli BL21 (DE3) E. coli host for protein 
expression 
Invitrogen 
M. smegmatis   
mc2155 WT strain of M. smegmatis This study 
KMS65 M. smegmatis mc2155 
carrying pCK206 
This study 
KMS98  ΔprcBAMs M. smegmatis 
mutant (prcBA::hyg) 
This study 
KMS108 KMS110 carrying pCK322 This study 
KMS109 KMS111 carrying pCK322 This study 
KMS110 KMS98 carrying pCK7  This study 
KMS111 KMS98 carrying pCK5 This study 
KMS116 KMS98 carrying pCK322 This study 
KMS128 KMS98 carrying pCK315 This study 
KMS153 KMS98 carrying pMH94 This study 
KMS157 KMS153 carrying pCK322 This study 
KMS179 M. smegmatis mc2155 
carrying pCK435 and pCK5 
This study 
KMS183 M. smegmatis mc2155 
carrying pCK435 and pMH94 
This study 
prcba ΔprcBAMs M. smegmatis 
mutant constructed 
independently by Barry group 
 
   
   
Plasmids   
pMH94  mycobacterial integration 
vector (Kanr) 
(52) 
pUAB100 mycobacterial protein 
fragment complementation 
vector 
(52) 
pCK3 pGEX-4T-3 (Ampr) carrying 
pknA under PT7   
(52) 
pCK4 pGEX-4T-3 carrying pknB 
under PT7   
(52) 
pCK5 pMH94 carrying pknA under 
Pacet (Kanr) 
(52) 
pCK7 pMH94 carrying pknB under 
Pacet (Kanr)  
(52) 
pCK21 pGEX-4T-3 carrying 
pknBK40M under PT7    
(52) 
pCK22 pGEX-4T-3 carrying (52) 
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pknAK42M under PT7   
pCK40 pET28a carrying 6His-Rv1422 
under PT7   
(52) 
pCK202 pMH94A (Aprar) carrying Pacet 
The Kmr gene in pMH94 
vector was replaced with Aprar 
gene from pCKACEI.  
This study 
pCK206 pCK202 carrying strep-prcA 
under Pacet  
This study 
pCK260 pRH1351 carrying a Hygr gene 
cassette in flanking regions of 
prcBA of M. smegmatis. 
This study 
pCK315 pUAB100A (Aprar). The Kmr 
gene in pUAB100 vector was 
replaced with Aprar gene from 
pMV261. 
This study 
pCK322 pUAB100A carrying prcBA-
strep under PHsp60 
This study 
 
 
 
Table 2. Strains and plasmids used in Chapter 3 
 
 
 
Strain 
 
 
Description 
 
Reference 
E. coli   
E. coli Top10 E. coli host for molecular 
cloning 
Invitrogen 
E. coli BL21 (DE3) E. coli host for protein 
expression 
Invitrogen 
M. smegmatis   
mc2155 WT strain of M. smegmatis (52) 
KMS65 M. smegmatis mc2155 
carrying pCK206 
(52) 
KMS98  ΔprcBAMs M. smegmatis 
mutant (prcBA::hyg) 
(52) 
KMS108 KMS110 carrying pCK322 This study 
KMS109 KMS111 carrying pCK322 This study 
KMS110 KMS98 carrying pCK7  This study 
KMS111 KMS98 carrying pCK5 This study 
KMS116 KMS98 carrying pCK322 This study 
KMS128 KMS98 carrying pCK315 This study 
KMS153 KMS98 carrying pMH94 This study 
KMS157 KMS153 carrying pCK322 This study 
KMS179 M. smegmatis mc2155 
carrying pCK435 and pCK5 
This study 
KMS183 M. smegmatis mc2155 
carrying pCK435 and pMH94 
This study 
   
   
Plasmids   
pMH94  mycobacterial integration (52) 
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vector (Kanr) 
pCK3 pGEX-4T-3 (Ampr) carrying 
pknA under PT7   
This study 
pCK4 pGEX-4T-3 carrying pknB 
under PT7   
(52) 
pCK7 pMH94 carrying pknB under 
Pacet (Kanr)  
(52) 
pCK21 pGEX-4T-3 carrying 
pknBK40M under PT7    
(52) 
pCK22 pGEX-4T-3 carrying 
pknAK42M under PT7   
(52) 
pCK40 pET28a carrying 6His-Rv1422 
under PT7   
(52) 
pCK202 pMH94A (Aprar) carrying Pacet 
The Kmr gene in pMH94 
vector was replaced with Aprar 
gene from pCKACEI.  
This study 
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APPENDIX C 
 
Table 3. Primers used in Chapter 2 
 
 
Primer Name 
 
 
Sequence 
TBprcBA pUAB100-F 5'-TGCAGATCTTTCGAACATGACCTGGCCGTTGCCCGATC-3' 
TBprcBA-C-strep3' 5'-AGTTTCCAGCTGTCACTTCTCGAACTGGGGGTGCGACCA 
GCCCGACGATTCGCCGTC-3 
Dn-PrcA-F 5'-GCGACAAACCCACCGAATAG-3’ 
Dn-PrcA-R 5'-TCATCTAGAATCCACGAGACGCTGGAC-3' 
Up-PrcB-F 5'-TCCTCTAGAGCTGCAACGCATCTACCTC-3' 
Up-PrcB-R 5'-CTATTCGGTGGGTTTGTCGCTTAATTAAAGTTCGGAGAAC 
GAGGA3' 
C-StrepTBprcB-5 5'-GACTAGCATATGACCTGGCCGTTGCCCGATC-3' 
∆prcBA-F 5'-CTGGAGACCACGCTCAAAC-3' 
∆prcBA-R 5'-GGGAGTCAGGCAACTATGGA-3' 
a712g_sense (T234A)  5'-ACGACTCCGCCGCCGGCGGTCCG-3' 
a712g_antisense (T234A) 5'-CGGACCGCCGGCGGCGGAGTCGT-3' 
a583g_sense(T195A) 5’-GGCAGTGCCGACGCCTCGGGTGGTG-3' 
a583g_antisense (T195A) 5’-CACCACCCGAGGCGTCGGCACTGCC-3' 
RV1422F 5’-CCAGGATCCGATGACCGATGGCATCGTC-3’ 
RV1422R 5’-CCTATCGATTCACTTCTCGAACTGGGGGTGCGACCATCG 
CCACGCGTCGTCAC-3’ 
 
 
 
Table 4. Primers used in Chapter 3 
 
 
Primer Name 
 
 
Sequence 
FbpB-5’ 5’-AGTCTAGCATATGACAGACGTGAGCCGAAAG-3’ 
FbpB-3’ 3’-TAGTCTAGATCACTTCTCGAACTGGGGGTGCGACCAGCCGGCGC 
CTAACGAACT-3’ 
A700gTAFbpBF 5’-GGGAGCGCAACGACCCTGCGCAGCAGA-3’ 
A700gTAFbpBR 5’-TCTGCTGCGCAGGGTCGTTGCGCTCCC-3’ 
FbpBTEF 5’-GGGAGCGCAACGACCCTGAGCAGCAGATCCC-3’ 
FbpBTER 5’-GGGATCTGCTGCTCAGGGTCGTTGCGCTCCC-3’ 
FbpBSA5 5’-CCTGCTGGACCCCGCCCAGGGGATGGGGC-3’ 
FbpBSA3 5’-GCCCCATCCCCTGGGCGGGGTCCAGCAGG-3’ 
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ABSTRACT 
 
ROLE OF THE PKNA AND PKNB KINASES IN MYCOBACTERIUM 
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To respond to environmental changes, M. tuberculosis possesses eleven 
"eukaryotic-type" Ser/Thr protein kinases. The aim of the study described in this 
dissertation was to identify role of two of these kinases; PknA and PknB that are essential 
in M. tuberculosis. Two approaches are described to screen for potential in vivo 
substrates of PknA/PknB. First approach is based on proteomic search by over-expressing 
PknA/PknB in M. tuberculosis. Proteomic search led to identification of proteasome to be 
a substrate of PknA and PknB in M. tuberculosis. Furthermore, I demonstrate that the 
phosphorylation of PrcA and PrcB by PknA regulates processing of Pre-PrcB. 
Additionally, I show that PknA phosphorylation of pre-PrcB and PrcA reduces the 
assembly of the proteasome complex and thereby enhances mycobacterial resistance to 
H2O2. Thus, H2O2 stress diminishes the formation of the proteasome complex in a PknA-
dependent manner. The second approach to identify potential in vivo substrates is by a 
homology search using the preferred phosphorylation motif ATQXIP identified based on 
already known in vivo substrates of PknA/PknB. This screen identified 7 new putative 
substrates of PknA/PknB and I chose to investigate the candidate substrate FbpB.  
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This study has confirmed the role of  PknA and PknB in regulating holo-proteasome 
assembly, function, and aso highlighted the possible role of M. tuberculosis proteasome 
in oxidatice stress response. The phosphorylation of proteasome is important for 
increasing resistance to H2O2 has been reported for the first time in this study. This study 
was also the first time that identified secreted form of FbpB has reduced mycolyl 
transferase activity when compared to intracellular FbpB and that the residue 234T is 
important for FbpB enzyme activity possibly due to their different phosphorylation status. 
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